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Waste activated sludge (WAS) pretreatment technologies are typically evaluated in terms of the 
associated improvement in biogas and sludge production during digestion and post-digestion 
dewaterability.  However, WAS properties, and hence the impact of pretreatment on WAS properties, 
are dependent upon the raw wastewater composition and configuration of the wastewater treatment 
plant (WWTP).  A generally accepted means of characterizing and comparing all pretreatment 
processes does not exist.  The motivation for this project was to evaluate the impact of pretreatment 
on WAS properties in terms of changes in COD fractionation.  The first objective of this study was to 
fractionate the COD of the WAS before and after pretreatment to show how pretreatment may 
increase the rate and extent of aerobic digestion.  The second objective was to develop a COD-based 
stoichiometric pretreatment model that may be integrated into WWTP simulations.     
 
A bench-scale biological reactor (BR) with a solids retention time (SRT) of 5 days was started up 
with WAS from the Waterloo WWTP.  The BR was fed daily with a completely biodegradable 
synthetic substrate so that the BR WAS contained only biomass and decay products after 3 SRTs of 
operation.  In the first phase of the study, an aerobic digester (AD) with a SRT of 10 d was fed daily 
with BR WAS.  The BR-AD system was operated at steady state for one month.  A range of physical 
and biochemical properties were regularly measured in each process stream.  Offline respirometric 
tests were regularly conducted to determine the aerobic degradability and fractionate the COD of the 
BR and AD WAS.  The oxygen uptake rate (OUR) associated with the daily addition of BR WAS to 
the AD was determined as an additional measurement of the aerobic degradability of the BR WAS.   
 
In the second phase of the study, the BR WAS was pretreated prior to being fed daily to the AD.  
High pressure thermal hydrolysis (HPTH) pretreatment was selected for this project since it is one of 
the most popular and promising pretreatment techniques.  A sealed volume of BR WAS was heated to 
150
o
C at 3 bars for 30 minutes.  The same physical, biochemical and biological tests used to 
characterize the process streams in Phase 1 were employed to characterize those in Phase 2.  The 
Phase 2 system was operated for two months at steady-state. 
 
The results of several independent tests showed that the COD of the BR WAS was comprised of 
storage products (XSTO) in addition to active heterotrophs (Zbh) and decay products (Ze).  However, it 




HPTH pretreatment did not reduce the TCOD concentration of the WAS however it did solubilize 56 
± 7% of COD, 49% ± 11% of organic nitrogen, 56 ± 10% of VSS and did not solubilize ISS.  
Furthermore, pretreatment did not generate soluble non-biodegradable COD.  These findings were 
consistent with prior research on HPTH WAS pretreatment.   
 
Pretreatment increased the rate at which the BR WAS was aerobically degraded.  The offline 
respirometric tests showed that the pretreated BR WAS contained a substantial amount of readily 
biodegradable COD (Sbsc).  However, pretreatment did not increase the extent of biodegradation.  The 
results of several independent tests showed that the non-biodegradable COD component of the BR 
WAS, i.e. Ze, was not converted to biodegradable COD by pretreatment.   
 
A COD-based stoichiometric pretreatment model was developed for the dose of HPTH pretreatment 
employed in this study.  When this model was integrated into BioWin®, it was able to accurately 
simulate both the steady state performance of the overall system employed in this study as well as 
dynamic respirometry results.  The experimental results showed that the TCOD of the BR WAS 
consisted of 51% Zbh, 12% Ze and 37% XSTO and the pretreated BR WAS consisted of 12% Ze and a 
negligible amount of Zbh.  The pretreatment model verified these fractions and predicted that the 
pretreated BR WAS also contained 54% Sbsc and 32% slowly biodegradable COD (Xsp).  The 
approach described in this study may be followed to determine the impacts of pretreatment on Zbh, Ze 
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The main by-product of biological wastewater treatment is waste activated sludge (WAS).  The use of 
biological wastewater treatment and hence the generation of WAS is increasing with population 
growth and the need to sustain water resources (Reynolds and Richards, 1996).  At the same time, 
sludge disposal to agricultural lands is becoming increasingly limited as sanitation standards become 
more stringent (Henze et al., 2008).  The sludge must be adequately stabilized and sterilized and its 
production minimized.   
 
WAS is typically stabilized by biological digestion to reduce pathogens, eliminate offensive odours 
and reduce the potential for putrefaction (Tchobanoglous et al., 2003).  In a time of continually rising 
energy costs, anaerobic digestion is preferred over aerobic digestion because it requires substantially 
less energy and generates methane which can be used as fuel.   Furthermore, anaerobic digestion 
produces a lower biomass yield than aerobic digestion, thereby reducing the energy demand 
associated with further processing or transporting the sludge.  However the significant disadvantage 
of anaerobic digestion is that it requires a long digestion time.  The anaerobic digestion process is 
composed of four stages: hydrolysis, acidogenesis, acetogenesis and methanogenesis (Henze et al., 
2008).  The hydrolytic reactions are considered to be the rate limiting step in the overall process (Li 
and Noike, 1992; Shimizu et al., 1993).        
 
Recent research has shown that various WAS pretreatment technologies have the potential to enhance 
the digestibility of the sludge, thereby reducing the required anaerobic digestion time.   In general, 
pretreatment causes the bacterial membranes in the WAS to rupture.  As a result, organic substances 
and nutrients are released.  These organics are more easily hydrolyzed (Wang et al., 1999).   A wide 
range of promising WAS pretreatment methods are currently being developed and a growing number 
of full-scale installations exist.  These technologies can be broadly categorized as thermal (Camacho 
et al., 2002; Donoso-Bravo et al., 2010 b; Tattersall et al., 2011), chemical (Deleris and Rouston, 
2000; Saby et al., 2002; Tanaka and Kamiyama, 2002; Appels et al., 2010), biological (Neyens and 
Baeyens, 2003) or mechanical (Tiehm et al., 2001; Chu et al., 2002; Braguglia et al., 2008) 
disintegration, with some technologies falling under more than one category (Musser, 2009).   
 
In order to characterize the impact of pretreatment on WAS, a variety of indicators have been 
employed.  Many of these indicators are based on the associated improvement in plant performance.  
For example, pretreatment has been shown to enhance methane generation during anaerobic digestion 
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(Wang et al., 1995).  These plant-performance indicators are however, heavily dependent on the raw 
sludge composition and configuration of WWTPs.  Hence it is difficult to apply the results of existing 
pretreatment studies to waste streams different from the stream used in the original study.  
Furthermore, it has been shown that some pretreatment doses such as ozonation and sonication are 
challenging to quantify (Musser, 2009).  A generally accepted means of characterizing and comparing 
all pretreatment processes does not exist.        
 
An essential design tool of biological wastewater treatment is the activated sludge model.  The 
International Water Association (IWA) has sponsored the development of standardized activated 
sludge model platforms.   The first activated sludge model, the IWA Activated Sludge Model Number 
1 (ASM1), was developed in 1987.  Since then increasingly more complex activated sludge models 
have been designed (Henze et al., 2008).  The concentrations of all organic components in the IWA 
activated sludge models are given in units of chemical oxygen demand (COD).  The COD is a 
consistent measure of the energy that is present in the wastewater.  In the ASMs, the organic 
wastewater constituents are separated into biodegradable versus non-biodegradable and soluble 
versus particulate COD fractions.  The development of a COD-based model that could describe WAS 





WAS pretreatment is typically evaluated in terms of the associated improvement in sludge digestion 
and biogas production.  However, WAS properties and hence the impact of pretreatment on WAS 
properties depend on the raw sludge composition and configuration of WWTPs.  A generally 
accepted means of characterizing and comparing all pretreatment processes does not exist.   The 
motivation for this project was to show the potential of using COD fractionation as a universal 
characterizer of WAS pretreatment.   
 
The most extensively researched and widely used WAS pretreatment technique is thermal 
pretreatment, in particular high pressure thermal hydrolysis (HPTH).  Full-scale installations of this 
type have been successfully used for more than a decade (Tattersall et al., 2011).  This type of 
pretreatment has the potential to produce Class A biosolids as defined by United States CFR 40 Part 
503.32 (USEPA, 1999).  Class A biosolids contain no detectable levels of pathogens.  In general, 
Class A biosolids may be used in small quantities by the public without buffer requirements or 
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restrictions on crop type, crop harvesting or site access.  HPTH pretreatment is of great interest to the 
wastewater industry because it holds the combined benefits of decreasing the biosolids production 
while improving the acceptability of biosolids (Wilson and Novak, 2009).  Based on its popularity 





This project aimed to: 
 Fractionate the COD of raw and pretreated WAS using analytical and bioassay methods to 
show how pretreatment may increase the rate and extent of aerobic digestion. 
 Develop a COD-based pretreatment model.   






This project investigated the impacts of thermal waste activated sludge (WAS) pretreatment in a 
bench-scale system and the experimental results were used to develop a pretreatment model.  The 
scope of this project included: 
 Operation of a bench-scale biological reactor (BR) initially seeded with activated sludge from 
the Waterloo WWTP, and then fed daily with synthetic wastewater to generate a stable source 
of WAS   
 Operation of a bench-scale aerobic digester (AD) fed daily with BR WAS in Phase 1, and 
then fed daily with thermally pretreated BR WAS in Phase 2 
 Characterization of the raw and pretreated BR WAS and the Phase 1 and 2 AD WAS with 
respect to pH, suspended solids and COD and nitrogen species 
 Assessment of the biodegradability and concentrations of active biomass and endogenous 
decay products of the various sludge streams by online and offline respirometric methods  




 Development of a COD-based thermal pretreatment model and integration of the model into a 




2. Background  
 









C (Climent et al., 2007).  Pretreatment at temperatures under 100
o
C is considered low 
temperature (LT) pretreatment.  Pretreatment at temperatures above 100
o
C is accompanied by 
elevated pressure and is referred to as high pressure thermal hydrolysis (HPTH).   
 
Research suggests that LT pretreatment enhances the bioactivity of some thermophilic bacterial 
populations with an optimum activity at temperatures around 70
o
C (Nielsen et al., 2004).  Although 
LT pretreatment requires considerably less energy input than HPTH, previous studies have shown 
that LT pretreatment is ineffective in improving sludge digestion.  Nielsen et al. (2011) reported that 
pretreatment at 80
o
C had no effect on methane yield in an anaerobic digester.  In a study carried out 
by Prorot et al. (2011), samples were tested at a constant heating time of 20 minutes while the heating 




C.  These researchers found that the cumulative biogas 
production in anaerobic conditions was very similar for both untreated and heat treated samples.  
Therefore, low temperature heat treatment did not seem to improve the anaerobic biodegradability of 
the sludge.   
 
HPTH pretreatment is much more promising than LT pretreatment.  HPTH disintegrates cells which 
releases intracellular matter that is more accessible to anaerobic microorganisms (Gurieff et al., 
2011).  This in turn reduces the sludge viscosity which eases the mixing of the digester.  Without 
good mixing, the solids settle in the digester and hence reduce the active volume.  Reducing the 
sludge viscosity therefore allows digesters to be operated at substantially higher organic loading rates 
(Morgan-Sagasume et al., 2010).  Furthermore HPTH produces volatile fatty acids (VFAs) and it has 
been found that the ratio of acetic to propionic acid in fermented HPTH is very similar to that needed 
for biological phosphorous removal.  Thus the dewatered digested sludge could potentially be 
recycled to the anaerobic reactor to promote the growth of polyphosphate accumulating organisms 




HPTH is becoming established worldwide as an effective sludge pretreatment technique due to its 
capacity to deliver Class A biosolids and enhance VSS reduction and methane production (Tattersall 
et al., 2011).  Producing Class A biosolids, as defined by the USEPA, provides more diverse disposal 
options (USEPA, 1999).  Several studies have shown that the increase in biogas production could be 
sufficient to preheat the WAS and heat the anaerobic digesters (Bougrier et al., 2007; Phothilangka et 
al., 2008; Gurieff et al., 2011).  The high temperatures are typically applied by heat exchangers or 
steam injection (Climent et al., 2007).  All these listed benefits provide significant operational cost 
savings.   The remainder of this chapter will focus on HPTH pretreatment, the selected type of 





Most HPTH pretreatment methods involve heating the sludge to temperatures in the range of 140 to 
200
o
C under a corresponding pressure of 3 to 25 bars.  Numerous studies have shown that within this 
temperature range, the duration of heating has less effect on the sludge properties than the treatment 
temperature (Bougrier et al., 2007; Climent et al., 2007).  The common heating time for HPTH 
pretreatment is 30 to 60 minutes.  Dwyer et al. (2008) showed that the organic matter became more 




C.  However, they 
monitored the soluble residuals after digestion, overall methane formation and hydrolysate organic 
acid concentration and showed that the additional solubilized materials were not degradable.  





et al., 2008).  Several reports have shown that HPTH pretreatment polymerizes low molecular weight 
intermediate compounds such as carbohydrates and amino acids to produce coloured recalcitrant 
refractory compounds (Bougrier et al., 2007; Climent et al., 2007; Dwyer et al., 2008; Donoso-Bravo 
et al., 2010 b).  Studies have reported that refractory compounds begin to form at temperatures as low 
as 150
o
C to as high as 190
o
C.  These refractory compounds are undesirable because they will 
contribute soluble non-biodegradable COD that could add to the treatment plant effluent stream if 
dewatering streams are recycled.   
 
HPTH pretreatment techniques have been commercialized and are in full-scale operation (Morgan-
Sagasume et al., 2010).  The most well-known is CAMBI
TM
 which has more than 25 installations 
worldwide (Abu-Orf and Goss, 2011).  CAMBI
TM
 reactors are operated in batch mode whereby the 
sludge temperature is initially heated to 80
o
C, followed by thermal hydrolysis at 165
o
C at 7 bars for 
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30 minutes.  The sludge then enters a flash tank where the steam is released and used to preheat the 
raw sludge (Abu-Orf and Goss, 2011).  Besides CAMBI
TM
, the only other commercial HPTH 
pretreatment technique that has been proven to produce Class A biosolids is Exelys
TM
.  Up to now, 
only one full-scale Exelys
TM
 pilot plant is in operation (at Hillerod, Denmark).  The Exelys
TM
 process 
operates at the same temperature, pressure and retention time as CAMBI
TM





 is a continuous plug flow system that uses a series of batch tanks and does not 
include a flash period (Gurieff et al., 2011).  It has been suggested that the flash period assists in 
disintegrating the sludge however Gurieff et al. (2011) showed that eliminating the flash period did 
not affect the COD solubilization.   
 
Based on the results of existing HPTH pretreatment research, a conservative temperature of 150
o
C 
was selected for this study with a corresponding pressure of 3 bars.  Heating the sludge at this 
temperature was expected to improve the degradability while minimizing the generation of soluble 





 processes.      
 
 
2.1.3 Physical Properties 
 
In the current project, the impact of HPTH pretreatment on the physical properties of WAS was 
assessed by monitoring the TSS and VSS.  This section presents a brief literature review of the impact 
of HPTH pretreatment on these parameters.    
 
Bougrier et al. (2008) pretreated five different WAS samples for 30 minutes at temperatures ranging 
from 90 to 210
o
C in a laboratory autoclave.  The authors showed that the VSS/TSS ratio decreased 
with the treatment temperature indicating that the particulates became more mineral in nature.  At 
150
o
C, the average VSS/TSS ratio was 72% whereas the ratio was 81% for untreated sludge.  In 
another study, the performance of the CAMBI
TM
 process was evaluated at three full-scale WWTPs 
(Morgan-Sagasume et al., 2010).  The authors showed that the CAMBI
TM
 process caused a decrease 
in TSS of 20 to 30% demonstrating that HPTH pretreatment solubilizes suspended matter.  In a third 
study, Gurieff et al. (2011) operated an Exexlys
TM
 pilot plant over a 9 month period and showed that 




      (2.1) 
In equation 2.1, VSSi and VSSf were the respective VSS concentrations before and after pretreatment 
and TS was the total solids concentration. 
 
 
2.1.4 Biochemical Properties 
 
In the current project, pH, COD and nitrogen species were measured in order to assist in fractionating 
the COD of the WAS before and after pretreatment.  Recently published related studies have 
considered the impact of HPTH pretreatment on these particular biochemical indicators.  The extent 
of solubilization of COD and nitrogen species may be used to assess the impact of pretreatment on the 
biodegradability of WAS (Kianmehr, 2010).  Solubilized materials are potentially more easily 
hydrolyzed than particulate materials.  The results of four HPTH studies are compared here. 
 
The desired pH range for anaerobic digestion is 6.6 to 8.2 (Parker, 2010).  Therefore it is important to 
assess the impact of HPTH pretreatment on the pH of WAS to determine whether pH adjustment is 
required before feeding the WAS to the anaerobic digester.  Bougrier et al. (2008) showed that the pH 
of the pretreated WAS increased from 6.9 at 90
o
C to 7.3 at 150
o
C then decreased to 6.8 at 170
o
C.  The 
authors postulated that the pH increase was due to protein desorption or acidic compound 
volatilization.  They suggested that the pH decrease could be linked to the degradation of 
macromolecules into acidic compounds.  Morgan-Sagasume et al. (2010) showed that the CAMBI
TM
 
process slightly decreased the pH of the WAS from an average of 6.7 to 6.2.  The results of these two 
studies indicate that HPTH at temperatures around 165 to 170
o
C slightly decreases the pH of the 
WAS. 
 
By far the most common indicator employed by the HPTH pretreatment studies referenced in this 
project is the COD solubilization caused by pretreatment.  In the four studies presented below, COD 
solubilization was calculated with equation 2.2:  
     (2.2) 
In this formula, SCODi and SCODf were the respective SCOD concentrations measured before and 
after pretreatment and PCODi was the initial particulate COD.  Bougrier et al. (2008) showed that 
COD solubilization increased linearly with temperature from 90
o
C up to 200
o
C.  The reported average 
COD solubilization at 150
o
C was 40%.    Donoso-Bravo et al. (2010 b) carried out lab-scale and pilot-
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scale HPTH pretreatment experiments on WAS in which the temperature and pressure were held 
constant at 170
o
C and 8 bars respectively while the contact time was varied.  This study showed that 
the SCOD concentration increased with contact time up to 15 minutes but there were no additional 
changes for a contact time of 30 minutes.  The COD solubilization was 45% at 30 minutes.  In a 
CAMBI
TM
 pretreatment study, Morgan-Sagasume et al. (2010) reported that the average COD 
solubilization was 39%.  These authors also reported that both the TCOD and TN concentrations 
remained unchanged by pretreatment, indicating that no significant degradation or removal of organic 
matter occurred.  Therefore, the HPTH process did not diminish the available resource for methane 
production.  In an Exexlys
TM
 pretreatment study, Gurieff et al. (2011) reported that the average COD 
solubilization was 28%.   Hence it can be observed that the COD solubilization results of these four 
studies were comparable and ranged from 28 to 45%.   
 
In terms of changes in the fractionation of nitrogen compounds, Bougrier et al. (2008) reported that 
the ammonia concentration increased with temperature up to 90
o
C, then remained constant at higher 
temperatures.  During thermal pretreatment, proteins may be broken down to polypeptides which may 
in turn be broken down to amino acids.  The amino acids may then be mineralized, i.e. cleaved to 
release ammonia.  The results of Bougrier et al. (2008) indicate LT pretreatment mineralized proteins.  
It is highly likely that further protein degradation occurred at the higher temperatures tested however 
mineralization did not occur above 90
o
C.  Donoso-Bravo et al. (2010 b) reported that HPTH only 
slightly increased the ammonia concentration, demonstrating marginal protein mineralization.  
Morgan-Sagasume et al. (2010) found that the mass of total nitrogen per mass of total solids in the 
sludge remained constant during thermal pretreatment.  Because the mass of TCOD per mass of total 
solids and mass of total phosphorous per mass of total solids also remained constant during 
pretreatment, these authors concluded that no significant degradation of organic matter occurred.  As 
previously discussed, these same studies showed that HPTH solubilized COD.  It can therefore be 
concluded that proteins were solubilized rather than mineralized by HPTH.     
 
 
2.1.5 Biological Properties 
 
The biological properties of WAS such as the activity of the biomass and biodegradability of the 
sludge are expected to be impacted by pretreatment.  In this part of the literature review, the 
biological impacts of HPTH pretreatment are discussed and the indicators that describe such impacts 
are introduced.   
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2.1.5.1 Activity of Bacteria 
 
The inactivation of bacteria in WAS caused by HPTH may be indicative of the conversion of biomass 
into a more readily biodegradable form (Kianmehr, 2010).  Disrupted, dead and inactive biomass may 
be disintegrated and hydrolyzed easier than active biomass.  The inactivation of biomass may also 
change the nature of the flocs and facilitate their disintegration. Donoso-Bravo et al. (2010 b) 
measured the total coliforms in the sludge before and after pretreatment at 170
o
C and 8 bars over a 
range of contact periods.  They found undetectable levels in every pretreated sludge sample.  Gurieff 
et al. (2011) tested samples before and after pretreatment by the Exelys
TM
 process for fecal coliforms, 
Enterococci and helminth eggs.  Unlike the CAMBI
TM
 process that is operated in batch mode, the 
Exelys
TM
 process is continuous and it is possible that some organisms may short-circuit the process 
and remain viable.  However they showed that the remaining organisms were below the detection 
limit.  It must be noted that the measurement of viable microorganisms in these studies was employed 
to determine whether the sludge could be considered sterile as defined by the USEPA for Class A 
biosolids.  The culturable microorganisms measured in these studies probably only comprised a small 
fraction of the total active heterotrophs present.    
 
A much more accurate method to measure the concentration of active heterotrophic bacteria is to use 
batch-mode respirometry.  In this method, the oxygen uptake rate (OUR) is determined over a period 
of time by measuring the consumption of dissolved oxygen in the WAS sample in an airtight vessel.  
In the current project, the active fraction is defined as the ratio of initial active biomass (mg COD/L) 
measured by respirometry to TCOD (mg COD/L).  Two approaches will be presented to determine 
the active fraction from OUR time-series data.  
 
In the first approach, a small volume of WAS is combined with a comparably large volume of 
substrate in the batch respirometric test such that the food to microorganism (F/M) ratio is greater 
than 10.  The measured OUR will increase exponentially with time, indicating that the bacteria are 
reproducing.  Once the substrate is depleted, the measured OUR will decrease with time.  Both 
Kianmehr (2010) and Musser (2009) successfully employed this approach to measure the 
concentration of active bacteria in WAS before and after pretreatment by sonication and ozonation.  
Wentzel et al. (1998) used equation 2.3 to determine the initial active biomass concentration (Zbh0) in 
mg COD/L on the basis of respirometry data: 
       (2.3) 
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In this formula, the slope and y-intercept are of the plot of ln(OUR) versus time (d) for the portion of 
the measured OUR data that exponentially increases with time.  The measured OUR is in units of mg 
COD/L/d.  The aerobic decay rate is represented as bh (d
-1
) and the aerobic yield coefficient is 
represented as Yh.  Kianmehr (2010) reported that estimates of Zbh0 were not significantly sensitive to 




C was used in the current project unless otherwise 
stated.  This is the value of bh recommended by Henze et al. (2008).  The typical value of Yh in real 
activated sludge systems is 0.67 (Henze et al., 2008).   In activated sludge systems fed by sodium 
acetate as the sole carbon source Yh values of 0.6 have been reported (Ramdani et al., 2012).  Unless 
otherwise stated, the Yh value used in the current project was 0.6. 
 
The second approach uses only WAS in a batch respirometric test.  The measured OUR will decrease 
exponentially with time, indicating that endogenous decay is the only oxygen-consuming process in 
the vessel.  A nonlinear regression fit of equation 2.4 to the measured OUR data will yield an estimate 
of Zbh0 in a sample (Jones et al., 2009). 
      (2.4) 
Where  OUR = measured oxygen uptake rate (mg O2/L/h) 
 fN = nitrogen content of heterotrophic organisms 
 f = endogenous decay product fraction of organisms (0.2) 
 t = time (days) 
In systems where nitrification is suppressed, the 4.33fN term is omitted to eliminate the nitrogenous 





HPTH pretreatment may impact the rate and extent of biodegradability of the WAS.  As demonstrated 
by Kianmehr (2010), the anaerobic biodegradability of the WAS may be measured using the 
biochemical methane potential (BMP) test or the biochemical acidogenic potential (BAP) test 
however these tests were outside the scope of this study.  This project focused on measuring the 
impact of HPTH on the aerobic degradability of the WAS using respirometric methods.  Several 
WAS pretreatment studies have employed respirometry to estimate the readily and slowly 
biodegradable COD concentrations in raw and pretreated WAS (Spanjers and Vanrolleghem, 1995; 
Mathieu and Etienne, 2000; Musser, 2009; Kianmehr, 2010).   Readily biodegradable COD is 
typically soluble whereas slowly biodegradable COD is particulate.  Since HPTH pretreatment has 
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been shown to solubilize organic materials, an increase in the level of readily biodegradable COD 
(rbCOD) or rate of aerobic biodegradability is expected when HPTH pretreatment is applied.   
 
Musser (2009) analyzed the effects of sonication and ozonation on the aerobic biodegradability of 
authentic WAS using respirometry.  F/M ratios between 0.1 and 10 were employed where neither the 
growth nor the decay processes were dominant.  Musser (2009) estimated the readily and slowly 
biodegradable COD concentrations by fitting OUR responses predicted by ASM1 to measured 
respirometric data.  OUR curves generated using ASM1 showed three distinct, successive phases that 
were defined by the dominant process in each phase: growth on rbCOD, growth on slowly 
biodegradable COD (sbCOD), followed by decay.  In this study typical values were assumed for all 
the kinetic and stoichiometric parameters, and hence the simulated respirometry responses were 
determined by the initial Zbh, rbCOD and sbCOD concentrations.  The active fraction was determined 
using the first approach described in the previous section.  Musser (2009) then used linear regression 
to fit the modeled response to the measured respirometric data to yield estimates of rbCOD and 
sbCOD.   
 
Similar to Musser (2009), Kianmehr (2010) analyzed the effects of sonication and ozonation on the 
aerobic biodegradability of WAS by employing respirometry to quantify the generation of rbCOD by 
pretreatment.   In this study samples with low F/M ratios were employed such that the substrate was 
depleted quickly in the respirometry test.  Kianmehr (2010) then developed an equation to estimate 
the concentration of rbCOD in the respirometry test.  In this equation, the rbCOD was calculated on 
the basis of the oxygen consumed during the rapid uptake portion of the test less the oxygen uptake 
that was attributed to endogenous decay.   
 
 
2.2 Existing Pretreatment Models 
 
Sludge pretreatment modeling is currently in the early stages of development.  A few research groups 
have proposed approaches for modeling WAS pretreatment technologies and an even fewer number 
have published stand-alone pretreatment models.  Lei et al. (2010) integrated the ASM2d and ADM1 
models into a proprietary whole-plant simulator that was employed to simulate a number of WWTPs 
employing sludge reduction technologies.  At one plant, RAS was treated with ozone.  The simulated 
data was fit to the measured data by testing a number of modifications to the ASM2d model that 
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could characterize the ozone treatment such as a COD reduction due to oxidation and mineralization, 
conversion of Xi to Xsp and conversion of Zbh to Xsp and Ze.  The results of this exercise were 
inconclusive because the sludge was not well characterized.  At another plant, WAS was pretreated 
by HPTH.  Lei et al. (2010) fit the simulations to the measured data by testing a number of 
modifications to ADM1 that were intended to characterize the impact of HPTH pretreatment such an 
increased digester hydrolysis rate and a partial conversion of inert decay products to carbohydrates, 
lipids and proteins.  The results of this study were also inconclusive.  Lei et al. (2010) recommended 
that further site-specific studies be carried out that focus on fractionating the COD in the sludge 
upstream and downstream of the sludge reduction technology. 
 
Phothilangka et al. (2008) developed and calibrated a plant-wide model of the Zirl WWTP by 
integrating the ASM1 and ADM1 models in a Matlab/SIMBA simulation environment.  At this plant, 
WAS was anaerobically digested then dewatered and the dewatering stream was recycled to the 
aeration basin.  A continuous HPTH process was later implemented at the plant whereby WAS was 
pretreated at 180
o
C under 19 to 21 bars prior to anaerobic digestion.  Similar to the approach taken by 
Lei et al. (2010), the original plant-wide model was adjusted to fit the data measured after 
pretreatment implementation by increasing the anaerobic disintegration rate and transforming inert 
decay products to biodegradable COD.   The authors demonstrated that the measured ammonia 
increase after digestion due to the HPTH pretreatment could only be explained by a complete 
degradation of decay products.  The measured COD concentration in the plant effluent increased after 
the HPTH process was implemented, indicating that the HPTH pretreatment process generated 
soluble non-biodegradable COD.  The calibrated model successfully predicted this increase.     
 
Dhar et al. (2012) monitored the performance of bench-scale anaerobic digesters that were fed with 
raw municipal WAS and thermo-chemical pretreated WAS respectively.  The impact of pretreatment 
was simulated using the BioWin 3.0 Activated Sludge Digestion Model.  Similar to the previously 
mentioned studies, these authors varied the digester hydrolysis rate to fit the simulations to the 
measured responses.  Dhar et al. (2012) concluded that pretreatment increased the hydrolysis rate by 
30% but did not enhance the digestibility of the sludge. 
 
Frigon and Isazadeh (2010) and Musser (2009) developed COD-based pretreatment models that were 
rate dependent and could be integrated into whole-plant simulators.  Frigon and Isazadeh (2010) 
developed and compared three hypotheses of the changes in COD fractionation that were caused by 
pretreating return activated sludge (RAS) with ozone.   An extension of the IWA-ASM3 model was 
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developed for each hypothesis and the model simulations were compared to the results of pilot-scale 
experiments and the findings of other researchers.  The first model extension hypothesized that 
ozonation transformed biomass to substrate COD and non-biodegradable COD with a small fraction 
of the COD being oxidized.  Storage products were similarly transformed except that non-
biodegradable COD was not generated from these materials.  In addition to these transformations, the 
second model extension assumed that inert and substrate solids were also transformed.  The third 
model extension contained the transformations of the second model extension and also included 
biomass inactivation processes.  This model extension was found to provide the best fit of test data.  
The inactivation of biomass and associated release of stored COD was shown to occur at a higher rate 
than the transformation rate of the solids COD fractions.  Frigon and Isazadeh (2010) found that the 
third model extension could be further improved by lowering the heterotrophic biomass level without 
further lowering the nitrifying biomass.  This could be achieved by assuming lower inactivation rates 
for nitrifiers than for ordinary heterotrophs or assuming nitrifying biomass metabolically adapted to 
the ozone treatment which would have changed parameters such as the maximum specific growth 
rate.   
 
Musser (2009) designed two separate COD-based stoichiometric pretreatment models, one for 
sonication and one for ozonation.  These models were based on experiments using WAS from the 
New Hamburg WWTP in Ontario.  Each pretreatment model was integrated into a WWTP simulation 
using BioWin version 3.0.  This simulator did not permit a simple stoichiometric conversion of COD 
species hence a rate-based approach was required to implement the pretreatment model into the 
simulator.  For each pretreatment model, Musser used the model builder reactor in BioWin.  In order 
to model different pretreatment doses, Musser set the HRT of the pretreatment reactor using equation 
2.5:  
 –           (2.5) 
In equation 2.5, w is the dose and k is the dose constant.  For simplicity, Musser converted only one 
biomass fraction, the heterotrophic biomass, in both his pretreatment models.    
 
During sonication, biomass was observed to be inactivated according to equation 2.6: 
–
–         (2.6) 
In equation 2.6, Zbh and Zbh0 were the final and initial heterotroph concentrations.  The experimental 
data showed that 45% of the inactivated biomass was converted to readily degradable substrate and 
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12% to slowly degradable substrate, which was assumed to be colloidal.  Musser (2009) assumed that 
8% of the inactivated biomass was cell residue and the remaining 35% was converted to slowly 
degradable particulate COD.  Musser’s experiments also showed that 57% of slowly degradable COD 
was converted to readily degradable COD and the remainder was converted to colloidal 
biodegradable COD.  This model therefore also included a separate process for this conversion.  Each 
conversion proceeded at a rate dependent on the ultrasound dose.  In Musser’s study and the current 
study, colloidal matter was defined as that which passed through a filter with a pore size of 1.5 μm 
but was retained by a filter with a pore size of 0.45 μm. 
 
Musser (2009) designed a model for the ozonation pretreatment process based on experimental 
findings of COD solubilization, heterotroph inactivation and nitrate production.  The ozone 
pretreatment data showed a rapid inactivation of heterotrophs and a much slower production of 
readily biodegradable COD (rbCOD); hence the process was modeled using two stages, both of which 
depended on the ozone dose.  In the first stage, heterotrophs were converted to slowly biodegradable 
COD (sbCOD) and in the second stage the sbCOD was converted to rbCOD.  These two stages were 
expressed by equations 2.7 and 2.8: 
(1)         (2.7) 
(2) –      (2.8) 
Similar to sonication, a cell residue fraction of 8% was assumed to remain after ozonation.  Musser’s 
ozone pretreatment model also included a process to convert nitrite to nitrate.  Each conversion 
process depended on the ozone dose.   
 
The simpler model proposed for sonication was based on the respirometric data whereas the more 
complex ozonation model was based on a combination of respirometric and nitrogen fraction data.  In 
both models the extent of heterotroph conversion increased with the pretreatment dose however the 
rate and maximum conversion differed (Musser, 2009).   
 
The sludge pretreatment modeling efforts discussed in this section were based on simulating real 
activated sludge systems before and after the application of a pretreatment technology.  Various COD 
transformations associated with pretreatment have been proposed.  However, these transformations 
were not solely empirical as the concentrations of some COD species were assumed.  It is challenging 
to accurately fractionate the COD of real activated sludge because it is comprised of a complex 
mixture of components such as rbCOD, sbCOD, Sus, Xi, biomass and decay and storage products and 
some of these components are not readily isolated.  For example, Xi cannot be distinguished and 
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separately measured from Ze when both are present in wastewater.  Therefore a change in the 
measured concentration of non-biodegradable particulate COD could be due to a change in the 
concentration of Xi or Ze or both.  Phothilangka et al. (2008) considered the transformation of Ze to 
bCOD but did not consider the transformation of Xi to bCOD.  Ramdani et al. (2010) have shown that 
the COD fractionation of activated sludge is substantially simplified when the system is fed with a 
synthetic soluble biodegradable substrate such as acetate.  The MLSS composition of real and 
synthetically-fed activated sludge systems is depicted in Figure 2.1 (Ramdani et al., 2010).  
 
Figure 2.1 MLSS Composition of Activated Sludge Systems (Ramdani et al., 2010) 
 
The COD concentrations of active biomass and endogenous decay products can be accurately 
measured using respirometric methods.  In this way, WAS generated from a synthetically-fed 
biological reactor may be completely fractionated in terms of COD.  Correctly characterizing the raw 
WAS would allow the fractionation of the pretreated WAS to be characterized more accurately.  For 
example, any soluble COD present in the pretreated WAS would be a direct result of pretreatment 
since soluble COD would be absent in the raw WAS from a synthetically-fed biological reactor.  In 
this project, WAS generated from a synthetically-fed biological reactor was fed to an aerobic digester 
for a period of time (Phase 1).  The WAS was then pretreated prior to being fed to the aerobic digester 
and the system was operated for an additional period of time (Phase 2).  The Phase 1 and 2 systems 
were each modeled and the models were calibrated using the measured COD fractions in the various 
WAS streams.  The models were then used to estimate any missing COD fractions.  In this way, it 
was possible to accurately determine the COD transformations caused by pretreatment.   
 
The stand-alone pretreatment models proposed by Musser (2009) and Frigon and Isazadeh (2010) 
were rate-based.  It is proposed that the pretreatment models may be simplified to stoichiometric 
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COD transformations, without compromising the robustness of the simulations.  The pretreatment 
models presented in this section were based on ozonation and sonication hence there is a need to 
develop an accurate model for the HPTH pretreatment process.      
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3. Materials and Methods 
 
3.1 Reactor Design and Materials 
 
The overall process flow diagrams for the reactors used in this project are shown in Figure 3.1 and 
3.2. 
 
Figure 3.1 Phase 1 Process Flow Diagram (Flow in L/d)  
 
 
Figure 3.2 Phase 2 Process Flow Diagram (Flow in L/d) 
 
A bench-scale synthetically fed biological reactor (BR) was used in this project to provide a source of 
stable WAS that consisted of active biomass and decay products.  This WAS was used to start up and 
feed, on a daily basis, a bench-scale aerobic digester (AD).  Once the AD had reached steady-state 
and was sufficiently characterized, a high temperature and pressure batch reactor was used to pretreat 
the BR WAS before it was fed to the AD.  
 
Two identical transparent acrylic watertight containers were used for the bench-scale BR and AD 
reactors.  These reactors were operated on a lab bench at a temperature of 20 ±1
o
C over the duration 
of the project.  The containers were cylindrical with an internal diameter of 20 cm, depth of 38 cm 
and total volume of 12 L.  Both reactors were fit with a transparent acrylic lid held in place by bolts.  
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A hole was drilled into the center of each lid and fitted with a bearing.  A stainless steel mixing shaft 
fitted with two propellers was inserted through this hole into the reactor.  Mixing in each reactor was 
provided by a Bodine® Model 0158 DC Gearmotor that was connected to a power converter.  Each 
mixer had a rotational speed of 200 rpm.  A photograph of the biological reactor and aerobic digester 
are shown in Figure 3.3. 
 
 
Figure 3.3 Biological Reactor and Aerobic Digester 
 
Each reactor was provided with two TetraTec® Whisper AP300 Deep Water Air Pumps.  In addition, 
the BR was equipped with two TopFin® AIR-3000 air pumps as well as the bench air supply.  The air 
was directed from the pumps and bench air valve through Top Fin® 6 mm diameter silicone airline 
tubing.  For the air supply from the TetraTec® pumps, the silicone tubes were connected to four 6 
mm diameter stainless steel tubes inserted into holes in the lid of each reactor.  The silicone tubing 
connected to the TopFin® pumps and bench air valve were inserted directly into the BR through a 3 
cm diameter opening in the lid.   
 
Liquid was removed from each reactor through a 6 mm stainless steel tube that was inserted into a 
hole in the lid.  This tube was connected to flexible tubing and a peristaltic pump.  Liquid was added 
to each reactor through a funnel inserted into a 3 cm diameter opening in the lid.   
 
The high temperature and pressure pretreatment of WAS was performed using a Parr® Model 4563 
Mini Pressure Reactor, shown in Figure 3.4.  This reactor treated a maximum liquid volume of 400 
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mL in batch mode.  Continuous stirring was provided during operation by a variable speed motor.  
This reactor can operate up to a maximum pressure of 68 bars and a maximum temperature of 225
o
C.  
Heating was provided by a mantle heater assembly connected to a programmable temperature control.  
Cooling was achieved by connecting the cold water tap on the lab bench to the cooling loop on the 
head of the reactor vessel using flexible tubing.  The vessel was fit with a thermocouple that was 
connected to a display so the temperature of the reactor contents could be monitored. 
 
Figure 3.4 Parr® 4563 Mini Pressure Reactor for HPTH Pretreatment 
 
 
3.2 Synthetic Wastewater 
 
A synthetic wastewater was used to provide the organics, trace metals, nitrogen, phosphorous and 
alkalinity required for bacterial cell maintenance and growth in the BR.  The selected synthetic 
wastewater recipe was adopted from Mohammadali and Hall (2011).  This recipe was modified by 
increasing the concentration of every compound by a factor of 12.5 except sodium bicarbonate and 
ammonium chloride which were increased by factors of 1.5 and 6.5 respectively.  This modification 
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resulted in a theoretical total COD (TCOD) of the synthetic wastewater of 4,000 mg COD/L.  It 
should be noted that from day 0 to 179 of the project, the synthetic wastewater concentrations were 
twice as high, i.e. theoretical TCOD of 8,000 mg COD/L.  The concentration was halved on day 179, 
at the beginning of Phase 1, because it was found that the aeration requirements in the BR could not 
be satisfied with the higher strength feed.  The minimum DO concentration in the reactor for 
uninhibited activity of aerobic heterotrophs is 2 mg O2/L.  The synthetic feed was prepared in stock 
solutions every 6 to 12 days and stored in the fridge.   The inorganic chemicals (Table 3.2) were kept 
in a separate solution from the organic chemicals (Table 3.1) to prohibit the growth of 
microorganisms in the stock solution that would have depleted the COD of the organic feed.  The 
yeast extract is listed with the organics to show its contribution to the TCOD however it was included 
with the inorganic stock solution because it also contained inorganic nutrients.  The compound 
concentrations in the synthetic wastewater fed to the BR are summarized in Tables 3.1 and 3.2. 
 
Table 3.1 Organic Synthetic Wastewater 
Organic Synthetic Feed COD Fraction Concentration (mg/L) 
yeast extract 0.12 350 
glucose (C6H12O6) 0.14 525 
starch (C6H10O5)n 0.23 775 
sodium acetate (NaCH3COO) 0.26 1315 
acetic acid (C2H4O2) 0.25 1100 
Column Total = 1  
  
Table 3.2 Inorganic Synthetic Wastewater 
Inorganic Synthetic Feed Concentration (mg/L) 
monopotassium phosphate (KH2PO4) 265 
sodium bicarbonate (NaHCO3) 167 
ammonium chloride (NH4Cl) 665 
magnesium chloride (MgCl2*6H20) 300 
calcium chloride (CaCl2*2H20) 450 
zinc sulphate (ZnSO4*7H2O) 5 
 
In order to enhance the flocculation process in the BR, a ferric chloride solution was added to the BR 
at the same time as the synthetic feed.  The influent concentration was 125 mg/L FeCl3*6H2O.  This 
was made using a stock solution of 17.54 g/L FeCl3*6H2O that was prepared every 28 days.        
 
Measurements of the COD, SS and pH of the synthetic feed were taken at least once per month 
throughout the project to monitor any fluctuations in the feed concentrations.  Both the fresh and two 
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week old stock solutions were measured and it was found that the COD did not change significantly 
during two weeks of storage in the fridge.  The COD fractionation of the synthetic feed will be 
presented in section 4.2.1. 
 
 
3.3 Operation of Reactors 
 
3.3.1 Biological Reactor 
 
The BR was operated from startup until the end of the project on day 283.  This reactor was operated 
as an SBR as shown in Figure 3.5.  At start-up, 5 liters of AS were collected from the aerated 
biological reactor at the Waterloo WWTP and added to the bench-top BR.  This provided the BR with 
a diverse spectrum of microorganisms.  The reactor was mixed continuously and aeration was 
provided such that the DO concentration remained above 2 mg/L.  After 5 hours, one liter of synthetic 
feed solution was added to the BR every hour until the total volume in the BR reached 10 L.   
 
 
Figure 3.5 Daily Operation of the Biological Reactor 
 
From Figure 3.5 it can be seen that WAS was removed from the BR while the reactor was being 
mixed and aerated.  Mixing and aeration were then ceased to allow the contents to settle.  Once the 
sludge blanket settled below the 5 L graduation mark on the reactor, 3 L of supernatant was siphoned 
off.  Mixing and aeration were then resumed and 5 L of synthetic feed was added to the reactor.  The 
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DO concentration in the reactor dropped to almost zero immediately after feeding however it was 
ensured that the DO concentration rose above 2 ppm within two hours after feeding and remained at 
that level for the remainder of the reaction period.  Steps 1 through 4 in Figure 3.5 typically required a 
total of 2 hours leaving approximately 22 hours for the reaction period.  These steps were repeated 
daily, 7 days per week.  The hydraulic residence time (HRT) of the BR was 2 d and the SRT was 5 d.   
 
The BR was cleaned twice per week throughout its operation.  This was necessary to remove any 
biofilm that collected on the inside walls and lid of the reactor as well as on the propeller blades and 
steel tubes inside the reactor.  The reactor was cleaned after the supernatant had been removed since 
this was the time when the reactor contained the smallest volume (5L).  The mixer and aerators were 
turned off and the lid was opened.  Tissues were used to wipe off the sludge collected on the inside lid 
and walls above the liquid level.   The propeller, shaft and steel tubes were removed from the liquid 
and wiped clean using tissues.  A clean handheld brush was used to scrape the biofilm from the walls 
below the liquid level.  During the third week of operation of the reactor, worms became visible on 
the inside walls and lid.  These worms were removed by hand and did not appear again.   
 
 
3.3.2 Aerobic Digester Fed with Raw BR WAS 
 
The aerobic digester was started up with BR WAS on day 20 and operated until the end of the project, 
day 283.  As will be shown in section 4.1, the BR was predicted to reach steady state conditions by 
day 15 hence it was assumed that the AD was started up with a stable WAS source.  On day 20, 2 L 
of WAS from the BR was poured into the AD and the mixer and aerators were turned on.  This was 
repeated for the following two days so that the AD contained 6 L of AS on day 22.  From day 23 until 
day 77, the AD was operated as a SBR with an HRT of 3 d and SRT of 10 d.  The BR-AD system 
was modeled in BioWin 3.1 and it was predicted that the AD reached steady state conditions within 3 
SRTs or 30 days from the day it was started up.  On day 77, the operation of the AD was simplified 
so that the HRT and SRT were both 10 d, as depicted in Figure 3.6.  This operation was continued 




Figure 3.6 Daily Operation of the Aerobic Digester (day 77 to 283) 
 
The main reason for changing the operation of the AD was to decrease the TCOD of the AD WAS so 
that the aeration requirements in the AD could be satisfied.  As mentioned in section 3.2, the 
minimum DO concentration in the reactor for the uninhibited activity of aerobic heterotrophs is 2 mg 
O2/L.  The second reason was to make available a portion of the BR WAS for running tests.  The 
entire daily volume of BR WAS was fed to the AD when the AD was operated as a SBR.  In the 
modified operating regime, only 30% of the daily BR WAS volume was fed to the AD.  This change 
in the operation of the AD was simulated using BioWin 3.1 and it was predicted that the AD reached 
steady state conditions after 3 SRTs, on day 107.   
 
Similar to the BR, the AD was cleaned twice per week throughout its operation.  The digester was 
cleaned when it contained the smallest volume of mixed liquor.  The AD was cleaned in the same 
way as the BR.  Unlike the BR, worms did not appear at any time during the operation of the AD. 
 
 
3.3.3 Aerobic Digester Fed with Pretreated BR WAS 
 
On day 203, pretreatment of the BR WAS that was fed to the AD was initiated on a daily basis.  The 
pretreatment reactor was always operated at its maximum capacity of 400 mL.  The mantle heater and 
programmable temperature controller were used to increase the temperature of the sludge to 150
o
C.  
This took approximately 20 minutes.  The Parr® 4563 reactor is a pressure vessel designed to prevent 
any gas or liquid from escaping.  At 150
o
C, the internal pressure was 3 bars.  No additional pressure 
was applied to the vessel.  The temperature was held at 150
o
C for 30 minutes.  The mantle heater was 
then turned off and removed from the reaction vessel and the cold water tap connected to the cooling 





C.   
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Once empty, the inside of the pressure vessel was washed clean in the sink using a brush with soap 
and water.  The lid and attached mixing shaft, cooling coil and sampling ports were also cleaned.  
These components were carefully inspected to insure no sludge remained before the next pretreatment 
batch was started.  
 
The AD required a daily feed of 600 mL.  In addition, up to 1 L of pretreated WAS was required to 
run tests.  To meet these volume requirements, the 2 L of WAS that was withdrawn from the BR was 
allowed to settle in a 2 L graduated cylinder until the sludge blanket level was below the 1 L 
graduation mark.  The supernatant was then siphoned off and retained.  The remaining 1 L of 
thickened sludge was then stirred and 400 mL was poured into the pretreatment reactor.  Following 
pretreatment, 300 mL of pretreated sludge was then diluted to 600 mL using the BR supernatant that 
had been removed from the graduated cylinder.  This sludge was then fed to the AD.  This sequence 
is illustrated in Figure 3.7. 
 
 
Figure 3.7  Daily Pretreatment Procedure (day 203 to 283) 
 
Under this operation, 100 mL of pretreated thickened sludge and 700 mL of BR supernatant were 
available daily for running tests.  There was also an excess volume of 600 mL of BR WAS that had 
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been thickened in the graduated cylinder.  On days when greater volumes of pretreated WAS were 
required for running tests, a second batch of thickened BR WAS was pretreated.    
 
 
3.4 Project Timeline and Sampling Schedule 
 
An overview of the monitoring and modeling conducted to address the objectives of the project is 
presented in Figure 3.8. 
 
Figure 3.8 Overall Framework for Characterization of Impacts of HPTH Pretreatment on WAS 
 
The project timeline is shown in Figure 3.9.  The focus of the project is the period from day 179 to 





Figure 3.9 Project Timeline 
 
When needed for characterization, samples of AS were taken from the BR and AD at the end of the 
reaction period, approximately 22 hours after the reactors had been fed.  While the reactors were 
being mixed and aerated, samples were withdrawn by inserting the sampling tube well below the 
liquid level and at least 5 cm away from the floor and walls of the reactor.  The sampling schedule is 
presented in Table 3.3. 
 










WAS from BR 
Day 0 to 20 Daily Once  Once    
WAS from AD and BR 
Day 20 to 92 Daily Bimonthly Monthly Bimonthly Monthly   
WAS from AD, Pretreated and Raw WAS from BR  
Day 92 to 112 Daily Weekly Weekly Weekly    
Day 112 to 134 Daily Weekly Weekly Weekly Weekly Weekly  
Day 112 to  160 Daily       
Day 160 to 236 Daily Weekly Weekly Weekly Weekly Weekly  
Day 236 to 283 Daily Weekly Weekly Weekly Weekly Weekly Weekly 
 
Two types of biological analyses were carried out on the activated sludge.  Offline respirometric tests 
were performed using a Challenge® AER-208 Respirometer.  The test was run until the endogenous 
OUR curve was clearly detectable which was typically between 100 to 160 hours.  Online 
respirometric tests were conducted by allowing the DO in the reactor to fluctuate by automatic 
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aeration control and then measuring the rate of decline of DO.  The online respirometric tests were 
conducted over three consecutive days.  The purpose of this measurement was to determine the OUR 
in the reactor throughout the 22 hour reaction period.  The offline respirometric tests were conducted 
bimonthly from day 83 to 173 and weekly from day 173 to 283.  The online respirometric tests were 
conducted monthly from day 173 to 204 and weekly from day 204 to 283. 
 
 
3.5 Analytical Methods  
 
The physical and biochemical indicators listed in Figure 3.8 were determined by conventional 
analyses.  These analyses were conducted according to the relevant sections of Standard Methods for 
the Examination of Water and Wastewater (Eaton et al., 2005).  Every sample was measured in 
duplicate.  Blank and standard samples were prepared and measured for all of the biochemical tests. 
 
 
3.5.1 Suspended Solids 
 
A volume of 5 mL was filtered through a prepared 1.5 μm pore size filter.  The residue and paper 
were dried to a constant weight in an oven at 105
o
C.  The increase in weight of the filter represented 
the total suspended solids (TSS).  The residue and paper were then placed in a furnace at 550
o
C for 45 
minutes.  The remaining solids represented the inorganic suspended solids (ISS) and the weight lost 





The total, soluble (sCOD) and flocculated and filtered COD (ffCOD) were measured at 600 nm using 
a HACH DR/2000 Spectrophotometer.  A range of standard samples were prepared and measured to 
generate a calibration curve.  For the total COD (TCOD) analysis, the samples were first 
homogenized for 30 seconds then diluted by an appropriate factor.   A volume of 2.5 mL of the 
emulsified, diluted sample was then added to the COD vial containing the reagents.  The vial was 
then mixed by being inverted several times and then placed in the preheated HACH COD Reactor for 
3 hours at 150
o




For the soluble COD (sCOD) analysis, 50 mL of the sample was centrifuged for 30 minutes.  The 
supernatant was then filtered through a Whatman Glass Microfibre filter (934-AH) with a pore size of 
1.5 μm.  The filtrate was then diluted if necessary, added to the COD vial and heated in the COD 
reactor identically to the TCOD sample.  It should be noted that both soluble and colloidal matter 
were measured in this sCOD procedure.  In this study, colloidal matter was defined as that which 
passed through a filter with a pore size of 1.5 μm but was retained by a filter with a pore size of 0.45 
μm.   
 
The flocculated and filtered COD (ffCOD) analysis is designed to measure the truly soluble COD.  
The sample was taken from the filtrate that had been collected for the SCOD sample.  A stock 
solution of 25 g/L of alum was prepared.  Using this stock solution, 2.5 mg of alum was added to a 50 
mL of the sample filtrate.  The sample was mixed vigorously for 30 seconds to begin flocculation, 
allowed to stand for 10 minutes, and then centrifuged for 15 minutes.  Finally the sample was filtered 
using a 0.45 μm pore size filter.  The filtrate was diluted if necessary, added to a COD vial, mixed 
and then heated in an identical manner to the TCOD and sCOD samples.  As mentioned, blank and 
standard samples were also subjected to this procedure.  This made it possible to detect whether the 





The concentration of ammonia in samples was measured using a Thermo Scientific Orion 
9512HPBNWP High Performance Ammonia Electrode.  The sample was taken from the filtrate that 
had been collected for the sCOD sample.  The ammonia probe was inserted into the sample while it 
was mixed continuously.  The pH of the sample was then raised to above 11 using a 5 M NaOH 
solution.  The ammonia reading was taken once the ammonia concentration had stabilized.  A 
calibration curve was prepared using ammonia standards every time a set of samples was measured.   
 
 
3.5.4 Total Kjeldahl Nitrogen 
 
Both total Kjeldahl nitrogen (TKN) and soluble TKN (sTKN) concentrations were measured.  
Samples analyzed for TKN measurements were first homogenized for 30 seconds.  The soluble 
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sample was taken from the filtrate that had been collected for sCOD analysis.  The digestion solution 
was prepared by dissolving 40 g potassium sulfate and 2 mL selenium oxychoride in 250 mL 
concentrated sulfuric acid and then diluting the solution to 500 mL with deionized water.  A volume 
of 1 mL of sample and 1.5 mL of digestion solution were added to a TKN digestion tube.  The tube 
was heated uncovered in a Bran & Lubbe BD-40 block digester first at 220°C for 1.5 h and then at 
380 °C for 2.5 h in order to convert organic nitrogen to ammonia.  This method was developed in the 
Environment Canada Wastewater Technology Center in Burlington, Ontario.  The ammonia was 
measured using the ammonia probe following the procedure described previously. 
 
 
3.5.5 Organic Nitrogen 
 
The organic nitrogen (ON) was estimated by subtracting the ammonia concentration from the TKN 






Nitrate was measured in the soluble sample taken from the filtrate that had been collected for sCOD 
analysis.  The sample was first diluted if necessary and then 25 mL of sample was poured into a 
sample cell and one HACH NitraVer® 5 Nitrate Reagent powder pillow was added.  Once sufficient 
time had elapsed for the cadmium reduction to complete, the sample was analyzed at 400 nm using 





The pH of the pretreated sludge and the activated sludge in the BR and AD was measured daily using 





3.6 Respirometric Methods  
 
Two respirometric methods were used in this project: online and offline.  Both methods were used to 
determine the oxygen uptake rate (OUR) and cumulative oxygen uptake (ΣOU) associated with the 
WAS from the BR.  The oxygen uptake data from both respirometric methods was used to assess the 
impact of pretreatment on the aerobic degradability of the WAS.  In addition, the oxygen uptake data 
from the offline respirometric test was used to determine the activity of the microorganisms in the 
WAS.  The overall goal of the respirometry measurements was to assist in fractionating the COD of 
the raw and pretreated WAS samples and hence only the carbonaceous oxygen demand was desired.  
The nitrogenous oxygen demand was inhibited by adding HACH 2533 nitrification inhibitor to the 
WAS.  The collection and analysis of respirometric data is not standardized hence the two approaches 
are described here in detail. 
 
 
3.6.1 Online Respirometry 
 
Online respirometry was used to measure the OUR and ΣOU in the aerobic digester over the reaction 
period.  Throughout the project, the temperature in the aerobic digester was 20 ±1
o
C and the pH was 
8.3 ± 0.2.  A Jenco© model LD-900-5-DO Industrial Inline DO Probe was used to continuously 
measure the DO concentration in the reactor.  This probe and the digester aerators were connected to 
a Jenco© model 6309-PDT Advanced Multi-Parameter Analyzer.  The probe, analyzer, aerators and 
AD are shown in Figure 3.10.  The analyzer was programmed to turn on the aerators when the DO 
concentration in the reactor declined to 3 mg O2/L and turn off the aerators when the concentration 
reached 5 mg O2/L.  An EasyLog© Model EL-USB-4 Data Logger was connected to the analyzer to 
record the DO concentration in the reactor every 10 seconds.  This logger could store up to 3.7 days 
of data; hence each online respirometry test was run for 3 days.  The rate of DO decline was 




Figure 3.10 DO Probe and Analyzer Connected to Aerators in the AD 
 
The nitrate levels in the aerobic digester were routinely measured as described in the previous section.  
Two grams of HACH 2533 nitrification inhibitor were added to the digester every two weeks to keep 




3.6.2 Offline Respirometry 
 
Offline respirometry was performed using a Challenge Technology© AER-208 Respirometer.  The 
temperature was set at 25
o
C for all respirometry tests and the pH was in the range of 8.1 ± 0.5.  This 
direct input respirometer replenished the oxygen consumed by the microorganisms in the sample by 
injecting oxygen bubbles into the sample headspace using fluid action (Young and Cowan, 2004).  
The pressure drop caused by the consumption of oxygen initiated the injection of the oxygen bubbles.  
Each flow cell was carefully calibrated to determine the mass of oxygen in one bubble.  The bubbles 
were counted by the respirometer and the ΣOU in each sample was recorded every 10 minutes.  The 
change in oxygen consumption for each time step was calculated to provide an estimate of the OUR 
in the sample bottle throughout the test.  Each offline respirometry test was run until a distinct decay 
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curve was observed, indicating that most of the aerobically biodegradable material had been 
consumed.  The test duration was typically 100 to 160 hours.   
 
The carbon dioxide gas produced by the aerobic heterotrophs was removed from the headspace by 
suspending a vial containing 30% w/w potassium hydroxide in the sample vessel.  In order to ensure 
that heterotrophic processes dominated all responses, 300 mg of HACH 2533 Nitrification Inhibitor 
was added to each sample bottle.  The total volume of each sample bottle was 250 mL and a 
maximum of eight sample bottles could be tested simultaneously.  The contents of the sample bottles 
were mixed using magnetic stir bars and the stirring rate was adjusted to produce a vortex that 
touched the stir bar.  The sample bottles were contained in a water bath so that the temperature could 
be held constant at 25
o
C.  The sample bottles, water bath, oxygen flow measurement cells and oxygen 
supply manifold of the respirometer are pictured in Figure 3.11.  The contents of the sample bottles 
for the offline respirometric tests are summarized in Table 3.4. 
 
 
Figure 3.11 Challenge Technology AER-208 Respirometer  
 
Table 3.4 Sample Bottle Contents for Offline Respirometric Tests 
Sample Bottle Whole Substrate Filtered Substrate Inoculum 
1, 2 150 mL  50 mL 
3, 4   50 mL 
5, 6 150 mL   




As shown in Table 3.4, every sample was tested in duplicate.  The WAS samples used in offline 
respirometry were taken from the reactors at the end of the reaction period.  In Table 3.4, the substrate 
was BR WAS in Phase 1 and pretreated WAS in Phase 2.  The filtered substrate was prepared in the 
same way that samples were prepared for the SCOD test, i.e. centrifuged then filtered through a 1.5 
μm glass fiber filter.  In Table 3.4, the inoculum was the AD WAS.  The F/M ratio in the inoculated 
bottles was 5 to 10 which was high enough to allow clear identification of the growth OUR response 
if present in the sample bottle.               
 
Once a month during Phase 2, offline respirometry was carried out on sample bottles containing only 
150 mL of BR WAS to verify that the active heterotroph concentration remained constant throughout 
the project.  On day 278, an alternative offline respirometric test was used to measure the active 
fraction of the BR WAS.  In this test, the sample bottles contained BR WAS and synthetic feed to 
yield F/M ratios in the range of 10 to 40.  The four pairs of bottles contained 0.5, 1, 2 and 4 mL of BR 
WAS, respectively, each topped up to 200 mL with synthetic feed.  Thus the BR WAS was diluted 
400, 200, 100 and 50 times, respectively, in the four pairs of bottles.  Respirometry carried out on 
control bottles consisting of water or synthetic feed showed zero oxygen uptake hence it was 








4.1 Startup of Reactors 
 
At the beginning of the project, the operation of the BR was simulated using the BioWin 3.1 
Integrated Model to predict the changes in concentration of the various COD components during the 
startup of the BR and estimate the time required for the BR to reach steady state.  This simulation was 
carried out for a number of reasons:   
 It was used to support the assumption that the COD components present in the seed sludge, 
which were absent in the synthetic feed, would be washed out of the BR.   
 It was used to show that at steady state, the BR WAS consisted of only active biomass and 
decay products.   
 It was used to estimate the date when the BR reached steady state.  This was required to 
select the startup date of the AD.  The AD needed to be started up with a stable BR WAS in 
order to minimize the time required for the AD to reach steady state.   
 A stable source of BR WAS was required for pretreatment in order to accurately characterize 
the impacts of pretreatment.    
 
As mentioned in section 3.3.1, the BR was initially seeded with 5 L of activated sludge from the 
Waterloo WWTP.  On the date the sample was taken from the WWTP, the TCOD of the activated 
sludge reported by the plant was 3280 mg/L.  The SRT of the aeration basin from which the sample 
was withdrawn was reported to be approximately 8 d.  Using these values, the aeration basin of the 
Waterloo WWTP was simulated in BioWin 3.1 to estimate the concentration of the major COD 
contributors in the activated sludge.  It was assumed that the plant received a continuous flow of 
typical settled medium-strength municipal wastewater that contained 450 mg/L TCOD, 15 mg/L ISS 
and 60 mg/L non-biodegradable particulate COD (Xi).  The MLSS of the AS therefore included a 
mixture of ISS and VSS.  The simulation was run until steady state conditions were reached.  The 
major COD contributors in the AS were predicted to be particulate inert COD (Xi), endogenous 
products (Ze), and ordinary heterotrophic biomass that does not accumulate phosphorus (Zbh).   
    
In a separate simulation, the bench scale BR was then modeled as an SBR with a 5 d SRT.  The 
activated sludge from the Waterloo WWTP predicted in the previous simulation was used as the seed 
sludge in the BR.  The influent parameters were specified according to the theoretical composition of 
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the synthetic feed used from day 0 to day 179 of the project, as shown in Table 4.1.  The COD:N:P 
ratio of the synthetic wastewater was 100: 4.4: 1.5.  This is very close to the conventionally 
recommended ratio of 100: 5: 1 for aerated activated sludge systems. 
 
Table 4.1 Influent Synthetic Wastewater Parameters 
Parameter 
Based on Synthetic Wastewater Recipe Converted to Required Units for BioWin 3.1® 
Concentration Units Concentration Units 
COD 8000 mg/L COD 8000 mg/L COD 
TKN 1330 mg/L NH4Cl 350 mgN/L 
TP 530 mg/L KH2PO4 120 mgP/L 
SCa 900 mg/L CaCl2*2H2O 245 mgCa
2+
/L 
SMg 600 mg/L MgCl2*6H2O 72 mgMg
2+
/L 
Alkalinity 333 mg/L NaHCO3 4 mmol/L 
 
Figure 4.1 shows the simulated COD fractionation in the activated sludge in the BR during the first 3 
days of operation.  In a given day, the biodegradable COD fractions sharply increased when the 
reactor was fed, corresponding to a sharp increase in TCOD.  The active organisms (Zbh) underwent 
rapid growth, and then began to decline when the substrate was depleted.  The endogenous products 
(Ze) steadily increased during the reaction period and began to accumulate in the reactor.  When the 
reactor was allowed to settle, the particulate COD concentrations dropped to zero because the model 
assumed perfect settling.   
 




The active heterotroph concentration in the BR at the end of the reaction period was predicted to 
drastically increase during the first three days of operation, as shown in Figure 4.1.  This was due to 
the relatively high strength of the synthetic feed compared to the assumed strength of the municipal 
wastewater at the Waterloo WWTP.  Consequently, the predicted Ze concentration also steadily 
increased in the BR.  The model predicted that Xi would be washed out of the BR within 3 SRTs or 
15 days.  As shown in Figure 4.2, the TCOD of the WAS was predicted to be almost entirely 
comprised of Zbh and Ze at steady state conditions which also occurred within 3 SRTs.  The TCOD of 
the BR WAS was measured on day 15 and was found to be 7700 ± 150 mg/L.  In this report, a 
number preceded by the symbol ± indicates one standard deviation above and below the mean of a 
sample set.  The predicted TCOD of the BR WAS at the end of the reaction period on this day was 
7790 mg/L which matched the measured value. 
     
Figure 4.2 COD Fractionation of WAS in BR Over 20 Days 
 
As mentioned in section 3.2, the synthetic feed concentration was halved on day 179.  It was 
predicted using another BioWin simulation that a new steady state condition would be reached within 
3 SRTs following this feeding change.  After day 194, the predicted steady-state TCOD, Zbh and Ze 
concentrations in the BR were half of the corresponding steady-state values shown in Figure 4.2.     
 
In conclusion, the simulation work presented in this section corroborated the findings of Ramdani et 
al (2010) that showed the activated sludge fed with synthetic substrate was comprised of only active 
biomass and decay products.  The BR was predicted to reach steady state within 3 SRTs from startup.  
It was therefore believed that when the AD was started up with BR WAS on day 20, it was fed with a 
stable WAS source.  Based on the simulations, the BR WAS was predicted to be changing in 
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composition from day 0 to day 15 and from day 179 until day 194.  Pretreatment experiments were 
therefore not carried out during these periods.    
 
 
4.2 Physical and Biochemical Characterization of Process Streams 
 
4.2.1 Synthetic Wastewater 
 
The concentration of conventional parameters in the synthetic feed obtained from the physical and 
biochemical analyses are presented in Table 4.2.  These values represent the concentrations observed 
throughout Phases 1 and 2 of the project, i.e. day 179 until day 283. 
 
Table 4.2 Concentration of Conventional Parameters in Synthetic Wastewater 
Parameter Avg. Concentration (mg/L) Std. Dev. (mg/L) 
TCOD 4006 183 
SCOD 2983 73 
ffCOD 2751 117 
ISS 100 61 
VSS 833 57 
pH 4.5 0.1 
 
The COD of the synthetic feed was fractionated into the components employed by the BioWin 3.1 
Integrated Model, as shown in Figure 4.3.  This allowed the synthetic substrate to be accurately 
represented in the Phase 1 and 2 system simulations which will be presented in section 5.  As shown 
in Table 4.2, suspended solids measurements of the synthetic feed revealed the presence of 100 ± 61 
mg/L of ISS.  Hence the AS in the BR contained some ISS at steady-state operation and thus deviated 
slightly from the ideal composition presented in Figure 2.1.  This ISS probably originated from the 
yeast extract.  The average measured ffCOD concentration in the BR WAS was 53 ± 12 mg COD/L 
and this was assumed to be soluble microbial products (SMPs) generated by the microorganisms in 
the reactor.  As explained by Kianmehr (2010), SMPs are soluble non-biodegradable COD.  
Therefore the net COD that bacteria converted in the BR was the measured TCOD of the synthetic 
feed less the measured ffCOD of the BR WAS which was 98.7 ± 6.1% of the TCOD of the synthetic 
substrate.  The activated sludge models used in this project are not capable of predicting the 
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channeling of COD into SMPs.  Therefore, for the purpose of modeling, the remaining 1.3% was 
assigned as Sus in the synthetic feed, as shown in Figure 4.3.  The slowly biodegradable COD fraction 
(25.5%) was obtained by dividing the average measured particulate COD by the TCOD.  It was 
assumed that 75% of the slowly biodegradable COD was particulate (Xsp) and the remainder was 
colloidal (Xsc).  The readily biodegradable COD fraction was obtained by subtracting the nbCOD and 
sbCOD from the TCOD.  As was shown in Table 3.1, half of the synthetic feed TCOD was from 
acetate hence the Sbsa fraction was assigned to be half the rbCOD.  The remaining rbCOD was 
assigned as complex (Sbsc).  
  
Figure 4.3 COD Fractionation of Synthetic Wastewater 
 
 
4.2.2 Biological Reactor 
 
As mentioned in section 4.1, the synthetic feed concentration was halved on day 179 and the BR 
reached steady state within 3 SRTs following this feeding change.  As shown in Figure 4.4, the 
concentrations of the COD and SS components measured by conventional analyses remained 
relatively stable from day 197 until the end of the project, day 283.  It was therefore concluded that 




Figure 4.4 COD and SS Concentrations in BR WAS 
 
The COD of the BR WAS was expected to be entirely comprised of biomass and associated products 
because the synthetic substrate was believed to be entirely oxidized within the reaction period in the 
BR.  This was shown in the reactor simulation presented in section 4.1.  Furthermore, the DO 
concentration in the BR dropped to almost zero immediately after the reactor was fed and then 
increased above 2 ppm within two hours, indicating that most of the substrate was depleted within 
this time.      
 
The data presented in Figure 4.4 was used to estimate several properties of the BR WAS.  The BR 
WAS contained an average ffCOD concentration of 53 ± 12 mg/L and this was assumed to be Sus 
from SMPs generated in the reactor.  In addition, colloidal COD was not present in the BR WAS 
because there was no significant difference between the measured SCOD and ffCOD concentrations.  
As explained by Kianmehr (2010), colloidal COD in WAS is typically comprised of extra cellular 
polymeric substances (EPS).  Therefore the BR WAS did not contain EPS that was in the colloidal 
range.  Besides the relatively small concentration of SMPs, the COD of the BR WAS was therefore 
entirely particulate.     
 
The average measured COD/VSS ratio of the BR WAS was calculated to be 1.23 ± 0.08.  This was 
less than the typical value of 1.42 (Henze et al., 2008) for active heterotrophs and endogenous 
residue.  The biomass in the BR was therefore more oxidized than typical biomass and it was 
hypothesized that this suggested the presence of stored COD such as glycogen or poly-hydroxy-
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alkanoates (PHA).  Although stored COD is not directly identifiable chemically, it may be recovered 
in COD analysis and must satisfy COD conservation.  The COD/VSS ratio of glycogen, a 
polysaccharide, has been reported to be 1.1 gCOD/gVSS (Ramdani et al., 2012).  Therefore the 
presence of glycogen in addition to active heterotrophs and decay products in the BR WAS would 
lower the average COD/VSS ratio below 1.42.   
 
The following section presents the derivation of a mass balance that was conducted to estimate the 
fraction of the biomass COD which was contributed by storage products.  In equations 4.1, 4.2 and 
4.3 below, the COD/VSS ratio of biomass is described by ϒZ, the COD/VSS ratio of stored COD is 
defined as ϒSTO and the average measured COD/VSS ratio of the BR WAS is defined as ϒOBS.  
Assuming that stored COD (XSTO) was present in the BR WAS and had an associated ϒSTO ratio and 
that the only other COD components in the BR WAS were active heterotrophs (Zbh) and endogenous 
residue (Ze), ϒOBS may be expressed by equation 4.1. 
       (4.1) 
 
The fraction of the TCOD that was present as storage products (fSTO) was equal to the ratio  and 
the TCOD was the sum of XSTO, Zbh and Ze.  These terms were substituted into equation 4.1 and it 
was rearranged to yield equation 4.2. 
      (4.2)  
 
Rearranging equation 4.2 to solve for fSTO yielded equation 4.3.   
       (4.3) 
Substituting the range of ϒOBS values and an assumed ϒSTO value of 1.1 into equation 4.3 yielded an 
average fSTO value of 54 ± 28%.  The results of this calculation indicated that more than half of the 
TCOD of the BR WAS was contributed by storage products.  Therefore, the heterotrophs in the BR 
did not use all of the synthetic biodegradable substrate for growth within the 5 d SRT and the 
concentration of active biomass in the BR was less than expected.  In a similar experiment, Ramdani 
et al. (2012) used an MBR with a 5.2 d SRT to treat a completely biodegradable synthetic influent 
comprised of sodium acetate as the sole carbon source.  These authors reported that the Zbh and Ze 
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fractions were 68 and 32% respectively.  Assuming an fSTO value of 54%, the sum of Zbh and Ze in the 
BR WAS was only 46% of the biomass COD.  The composition of the BR WAS therefore deviated 
from the composition reported by Ramdani et al. (2010) in Figure 2.1.  It is important to note that the 
calculated standard deviation of the average fSTO value was ± 28%, which was high.  The calculated 
fSTO ratio was found to be very sensitive to the ϒOBS value.     
 
Because the AD was fed with BR WAS, some properties of the AD WAS could be estimated based 
on the properties of the BR WAS.  First, the COD of the BR WAS consisted of Zbh, Ze and XSTO 
hence the AD WAS was expected to be comprised of biomass and associated products.  Furthermore, 
it was expected that the XSTO present in the BR WAS would be assimilated to AD biomass because 
the digester had an SRT twice as long as that in the BR.  Thus the AD WAS was expected to be 
mainly comprised of Zbh and Ze.  In addition the AD WAS was expected to contain concentrations of 
SCOD and ffCOD similar to those measured in the BR WAS.  It was hypothesized that the small 
concentration of SMPs believed to be present in the BR WAS were generated by biomass growth.  
Because biomass growth was not expected to occur in the AD, additional SMPs were therefore not 
expected to be generated in the AD.  The properties of the WAS from the AD will be discussed 
further in section 4.2.4.             
 
 
4.2.3 Effects of Pretreatment on BR WAS 
 
The pH was measured in the BR throughout the project as one way of assessing the stability of the 
reactor.  The pH of the BR WAS remained relatively constant throughout Phases 1 and 2 of the 
project, as shown in Figure 4.5, indicating reactor stability.  Pretreatment slightly decreased the pH of 
the WAS from an average of 8.5 ± 0.1 to 7.8 ± 0.2.  Both the original and lower pH values were 
within the range reported by Tchobanoglous et al. (2003) for uninhibited heterotroph activity hence 
pH adjustment was not required before the pretreated WAS was fed to the AD.  This pH decrease was 
expected as it has been shown that HPTH pretreatment produces volatile fatty acids (Morgan-




Figure 4.5 Measured pH in Raw and Pretreated BR WAS 
 
Pretreatment substantially solubilized COD, as was expected based on the results of published HPTH 
pretreatment studies.  The average concentration of each COD species in the raw and pretreated WAS 
was calculated over the period from day 194 to 283, i.e. while the BR was operating at steady state.  
For each measurement, the PCOD was calculated by subtracting the SCOD from the TCOD.  As 
shown in Figure 4.6, the sCOD and ffCOD concentrations calculated using equation 2.2 increased by 
56 ± 7% and 41 ± 5% respectively due to pretreatment.  By comparison, the range of COD 
solubilization reported in the HPTH pretreatment studies referenced in section 2.1.4 was 28 to 45%.  
In these studies, the pretreatment temperature ranged from 150 to 170
o
C and the soluble COD was 
defined as that passing through filters with pore diameters ranging from 0.45 to 1.6 μm.  The 
pressure, duration of heating and mode of operation also differed among the referenced studies.  
Therefore a direct comparison between the COD solubilization values measured in this project and 
those measured in the referenced research could not be made.  The BR WAS did not contain colloidal 
COD whereas the difference between the SCOD and ffCOD measurements in the pretreated WAS 
showed that it contained a colloidal COD concentration of 644 ± 285 mg/L.   Kianmehr (2010) 
suggested that the increase in colloidal COD due to pretreatment could result from the solubilization 




Figure 4.6 Average COD Concentrations in Raw and Pretreated BR WAS 
 
As shown in Figure 4.6, the TCOD concentration remained unchanged by pretreatment, indicating no 
significant removal of organic matter occurred.  This was consistent with the results of Morgan-
Sagasume et al. (2010) where TCOD was observed to be conserved during CAMBI
TM
 pretreatment. 
Pretreatment caused a noticeable colour change in the WAS in both the supernatant and the settled 
sludge.  The colour changed from light brown to dark brownish purple.  Because the COD was 
measured by spectrophotometry, it was necessary to determine whether this colour change affected 
the COD measurement.  Samples of raw and pretreated WAS were prepared at the same dilution 
factor.  Four replicate bottles of each sample were prepared and a potassium hydrogen phthalate 
solution of a known COD concentration was added to two of the bottles.  Four replicate bottles 
containing only the COD standard were also prepared.  The bottles were then analyzed for COD 
according to the method described in 3.5.2.  For each bottle containing dosed COD and WAS, the 
COD of the standard was calculated as the measured TCOD of this bottle less the measured COD of 
the bottle containing WAS only.  The results showed no significant difference in the measured COD 
of the standard among all the bottles, including the bottles containing only standard.  This test was 
repeated for filtered WAS samples and again no significant difference in the measured COD of the 
standard was observed among all the bottles.  Therefore the colour change imparted by pretreatment 
to the supernatant and sludge did not interfere with the COD measurement.   
 
Suspended solids measurements were carried out on the raw and pretreated BR WAS on 12 separate 
days during Phases 1 and 2.  On the basis of these measurements it was concluded that the organic 
suspended solids were preferentially solubilized by pretreatment as compared to the inorganic 
45 
 
suspended solids.  As shown in Figure 4.7, the average VSS concentrations before and after 
pretreatment were 3342 ± 167 mg/L and 1518 ± 230 mg/L, respectively.  A t-test at the 95% 
confidence level revealed that pretreatment caused the VSS concentration to decrease by 1824 ± 284 
mg VSS/L.  The average ISS concentrations before and after pretreatment were 489 ± 103 mg/L and 
412 ± 131 mg/L, respectively, and a t-test at the 95% confidence level showed no significant 
difference between these average values.   
 
Figure 4.7 Average SS Concentrations in Raw and Pretreated BR WAS 
 
In a study of the CAMBI
TM
 pretreatment technology, Morgan-Sagasume et al. (2010) reported that 
pretreatment caused the TSS concentration to decrease between 20 and 30%, according to equation 
4.4:   
     (4.4) 
To compare the results of this study to those reported by these authors, the decrease in the TSS 
concentration due to pretreatment was calculated for each of the 12 sampling days.  The average 
decrease in TSS concentration due to pretreatment was 49 ± 6% which was higher than that reported 
by Morgan-Sagasume et al. (2010).  A t-test at the 95% confidence level showed that the average TSS 
concentration decreased 1899 ± 205 mg/L due to pretreatment in the current study.  
  
Bougrier et al. (2008) reported a 9% decrease in the VSS/TSS ratio of a sludge that was pretreated at 
150
o
C.  In order to compare the results of this study to those reported by these authors, the VSS/TSS 
ratio was calculated for the raw and pretreated WAS on each day the suspended solids were 
measured.  The average VSS/TSS ratio before and after pretreatment was 87 ± 15% and 77 ± 8%, 
respectively.  A t-test at the 95% confidence level showed no significant difference between these two 
averages.  However, at the 90% confidence level, the VSS/TSS ratio decreased 10 ± 9% due to 
pretreatment which is comparable to the findings of Bougrier et al. (2008).   
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On each sampling day, the VSS destruction was calculated according to equation 4.5 using the 
measured VSS concentration of the BR WAS (VSSBR) and pretreated BR WAS (VSSPT).  The 
average VSS destruction due to pretreatment was found to be 56 ± 10%.  In summary, the bench-scale 
pretreatment used in this project was deemed to be representative of full-scale processes because the 
measured effects of pretreatment on pH, SS and COD species were found to be comparable to similar 
published research.   
     (4.5) 
 
The concentrations of various nitrogen species before and after pretreatment are presented in Figure 
4.8.  The concentrations of these species were measured in the raw and pretreated WAS on 7 separate 
days during Phases 1 and 2.  The concentrations of ammonia and nitrate in both types of WAS were 
measured on 5 additional days.  
   
Figure 4.8 Average Concentration of Nitrogen Species in Raw and Pretreated BR WAS 
 
A t-test at the 95% confidence level showed that the total nitrogen (TN) which included nitrate, 
ammonia and soluble and particulate organic nitrogen was not significantly altered by pretreatment.  
Another t-test at the 95% confidence level showed that the ammonia concentration was not 
significantly changed by pretreatment.  This indicates that significant mineralization of organic 
nitrogen did not occur.  By comparison, Bougrier et al. (2008) and Donoso-Bravo et al. (2010 b) both 
reported that HPTH pretreatment slightly increased the ammonia concentration.  Because both the 
total nitrogen and ammonia concentrations were unaltered by pretreatment, the organic nitrogen (ON) 
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concentration also remained unchanged.  However, as shown in Figure 4.8, ON was solubilized.  The 
average ON solubilization was 49% ± 11%, as calculated according to equation 4.6. 
     (4.6) 
 
The nitrogen content of the organics was calculated by dividing the measured particulate ON (pON) 
by the measured particulate COD (PCOD).  The average pON/PCOD ratios before and after 
pretreatment were found to equal 0.053 ± 0.006 mgN/mgCOD and 0.052 ± 0.016 mgN/mgCOD, 
respectively.  A t-test revealed that there was no significant different difference between these means 
at the 95% confidence level. This indicates that all types of particulate organics were solubilized to 
the same extent by pretreatment.   
 
The measured pON/PCOD values were less than the typical value of 0.07 mgN/mgCOD reported by 
Henze et al. (2008) for active biomass and decay products which suggested the presence of storage 
products such as glycogen or PHA that do not contain nitrogen.  A mass balance approach on the 
nitrogen species was therefore employed to estimate the contribution of storage products to the 
biomass COD.  In equations 4.7 and 4.8 below, the measured pON/PCOD ratio was defined as fNOBS, 
the typical pON/PCOD ratio for biomass was defined as fNZ and the pON/PCOD ratio for stored 
COD was defined as fNSTO.  Assuming that XSTO was present and that the PCOD consisted of XSTO, 
Zbh and Ze, the fNOBS value may be expressed by equation 4.7. 
      (4.7) 
 
The value of fNSTO was assumed to be zero and the fraction of the PCOD that was present as storage 
products (fSTO) was equal to the ratio .  Substituting these values into equation 4.7 and solving for 
fSTO yielded equation 4.8. 
        (4.8)  
 
Substituting the range of fNOBS values measured in the BR into equation 4.8 yielded an average fSTO 
value of 25 ± 9%.  As mentioned in section 4.2.2, the average fSTO values calculated using equation 
4.3 were 54 ± 28%.  Thus the difference between the fSTO values calculated using equations 4.3 and 
4.8 was 29% and a t-test at the 95% confidence level revealed that this difference was significant.  It 
is believed that the fSTO values estimated using equation 4.8 were more reliable that those estimated 
using equation 4.3 because only one value (fNZ) was assumed in this approach whereas two values 
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(ϒZ and ϒSTO) were assumed in equation 4.3.  The fSTO values were shown to be sensitive to the 
assumed values in both equations.  From a practical standpoint, it seems unlikely that the mass of 
COD stored within the cells could be much higher than the mass of the cells. 
 
The soluble nitrogen (sN) was calculated as the sum of the nitrate, ammonia and soluble organic 
nitrogen.  Based on the calculated decrease in VSS concentration caused by pretreatment (VSSdestroyed) 
and the pON/PCOD and COD/VSS ratios measured in the BR WAS, the expected increase in soluble 
nitrogen due to pretreatment was 119 ± 24 mgN/L, as determined by equation 4.9. 
  (4.9) 
 
Based on seven independent measurements of the nitrogen species in the raw and pretreated WAS, 
the average soluble nitrogen increase due to pretreatment was 118 ± 26 mgN/L.  A t-test at the 95% 
confidence level showed no significant difference between the measured values and the expected 
values calculated by equation 4.9.   
 
In summary, the HPTH pretreatment employed in this study substantially solubilized the COD of the 
WAS while conserving the TCOD.  Furthermore, organics were preferentially solubilized over 
inorganics.  These findings are supported by the results of similar published research.  Lastly, the 
analyses of the nitrogen species in this study indicated that pretreatment solubilized rather than 
mineralized proteins and that all types of particulate organics were solubilized to the same extent by 
pretreatment.          
 
 
4.2.4 Aerobic Digester 
 
The pH in the AD was measured throughout the project as one way of assessing the stability of the 
digester.  The pH remained relatively constant during Phases 1 and 2 despite the fact that it was 
receiving feed with a lower pH in Phase 2 than in Phase 1.  The measured pH of the AD WAS from 
day 179 until the end of the project is shown in Figure 4.9.  The pH remained within the range 
reported by Tchobanoglous et al. (2003) for uninhibited heterotroph activity.  During Phase 1, the 
average pH of the AD WAS was 8.43 ± 0.09 compared to 8.33 ± 0.17 during Phase 2.  A t-test at the 
95% confidence level revealed no significant difference between the Phase 1 and 2 average values.  
During Phases 1 and 2, the average pH of the AD WAS was 8.30 ± 0.20.  As mentioned in section 
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2.1.4, HPTH has been linked to the degradation of macromolecules into acidic compounds such as 
volatile fatty acids.  The insignificant pH decrease in the AD WAS from Phase 1 to 2 suggests that 
the acidic compounds believed to be generated by the pretreatment process were biodegraded in the 
AD. 
 
Figure 4.9 pH in AD WAS 
 
The COD and SS species in the AD were measured by conventional analyses throughout Phases 1 
and 2 of the project to assess the performance of the digester.  As previously mentioned, the 
concentration of the synthetic substrate fed to the BR was halved on day 179.  Consequently, the 
concentrations of the COD and SS species in both the BR and AD steadily decreased following this 
change.  From day 197 until the end of the project the measured TCOD, SCOD, ffCOD and VSS 
concentrations in the AD remained relatively stable, despite the fact that the AD feed was switched 
from raw to pretreated BR WAS on day 203, i.e. at the beginning of Phase 2. 
   
The average concentrations of the COD species were calculated for the stable period of Phase 1 (day 
197 to 203) and Phase 2 (day 203 to day 283) and plotted in Figure 4.10.  The average PCOD, SCOD 
and ffCOD concentrations decreased 12%, 23% and 7%, respectively, from Phase 1 to 2.  T-tests at 
the 95% confidence level showed that the decreases in PCOD and SCOD were significant whereas 
the decrease in ffCOD was insignificant. However, the decreases in PCOD and SCOD were 
considered relatively small.  Because the measured ffCOD concentrations in the AD WAS were 
equivalent in Phases 1 and 2, it was deduced that pretreatment did not generate Sus at the pretreatment 
temperature of 150
o
C that was employed in this study.  This finding is in agreement with previous 
research which showed that HPTH pretreatment only produced refractory compounds that were 
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essentially Sus when the temperature was above 150
o
C (Bougrier et al., 2007; Climent et al., 2007; 
Dwyer et al., 2008; Donoso-Bravo et al., 2010 b). 
 
Figure 4.10 Average COD Concentrations in Phase 1 and 2 AD WAS 
     
The observed stability of the measured TCOD, SCOD, ffCOD and VSS concentrations in the AD 
from day 197 until the end of the project is shown in Figure 4.11.  During this period the average 
measured COD/VSS ratio of the AD WAS was calculated to be 1.44 ± 0.11.  A t-test hypothesis at 
the 95% confidence level showed that this value was equivalent to the typical value of 1.42 for active 
biomass and decay products.  This validated the assumption that the AD WAS consisted entirely of 
these two components during Phases 1 and 2.  Hence, it was concluded that any storage products that 





Figure 4.11 COD and SS Concentrations in AD WAS 
 
The AD WAS contained some colloidal COD based on the data presented in Figure 4.11.  A t-test at 
the 95% confidence level showed a significant difference between the average measured SCOD and 
ffCOD concentrations in the AD WAS.  This difference, calculated to be 88 mg/L, was the colloidal 
COD concentration and it comprised 4 ± 1% of the TCOD of the AD WAS.  As reported in section 
4.2.3, the BR WAS did not contain significant concentrations of colloidal COD hence it would appear 
that a small amount was generated in the AD during Phase 1.  The pretreated BR WAS contained an 
average colloidal COD concentration of 644 ± 285 mg/L hence most of this was removed in the AD 
during Phase 2.  
  
Based on the average measured ffCOD concentrations in the BR and AD WAS, it would appear that 
Sus was generated in the digester in addition to that generated in the BR.  The average ffCOD 
concentration in the AD WAS was 133 mg/L higher than that in the BR WAS and a t-test at the 95% 
confidence level showed that this difference was significant.  This difference was attributed to 
additional Sus that was generated in the digester which suggested that the Sus was generated by 
endogenous decay rather than by growth.  Similar to the Sus generated in the BR, the Sus generated in 
the AD was probably due to the production of SMPs.  Many studies have shown that the majority of 
soluble organic matter in WWTP effluent is of microbial origin (Namkung and Rittmann, 1986).  A 
portion of the SMPs generated in the AD may have been due to the decay of bacteria that stored 
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COD.  For example, Sus generation upon the decay of polyphosphate accumulating organisms (PAOs) 
has been included in the BioWin Integrated Model®.  
 
Figure 4.12 shows that switching from raw to pretreated feed did not alter the VSS concentration of 
the AD WAS.  The average VSS concentration of the AD WAS was 1667 ± 117 mg/L in Phase 1 and 
1557 ± 90 mg/L in Phase 2 and a t-test at the 95% confidence level revealed no significant difference 
between these two average values.  This indicates that pretreatment did not change the fraction of the 
BR WAS that could be biodegraded by the AD biomass, despite the fact that the organics in the 
pretreated WAS were substantially more solubilized than the organics in the raw WAS.  With the 
HRT employed in the AD it was expected that the VSS concentration in the AD would have 
decreased had pretreatment increased the extent of aerobic biodegradability of the digester feed.  
  
Figure 4.12 Average SS Concentrations in Sludge Streams in Phases 1 and 2 
 
The VSS removal in the AD was calculated according to equation 4.10.  The average VSS removal in 
the AD was 50 ± 7% in Phase 1.  According to Tchobanoglous et al. (2003), VSS reductions ranging 
from 35 to 50% are achievable by aerobic digestion with an SRT of 40 d at 20
o
C.  Thus the VSS 
reduction in the Phase 1 AD was at the upper end of the reported range despite the fact that the SRT 
was only 10 d.  It is important to note that the reported range was for aerobic digesters treating WAS 
from WWTPs with primary treatment where 20 to 35% of the WAS is assumed to be non-
biodegradable.  The high observed VSS reduction in the Phase 1 AD was likely due to two reasons.  
First, the non-biodegradable fraction of the WAS was expected to be lower than typical because the 
system in this study was fed with synthetic wastewater that did not contain Xi.  Therefore, the non-
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biodegradable particulate COD fraction of both the BR and AD WAS consisted only of Ze.  Second, a 
substantial fraction of stored COD was present in the BR WAS and this was likely more 
biodegradable than Zbh.   
     (4.10) 
 
Using equation 4.10, it was shown that VSS removal did not occur in the AD in Phase 2.  A t-test at 
the 95% confidence level showed that the average VSS concentration of the pretreated BR WAS was 
equivalent to that of the Phase 2 AD WAS.  Thus the digester did not remove VSS beyond that which 
had been removed by pretreatment.  This was expected because pretreatment substantially solubilized 
organic matter, as was shown in section 4.2.3. 
 
Although the TCOD, SCOD, ffCOD and VSS concentrations remained relatively stable in the AD 
during Phases 1 and 2, the average ISS concentration decreased 46% in Phase 2, as shown in Figure 
4.12.  A t-test at the 95% confidence level showed that this decrease was significant.  Ramdani et al. 
(2012) showed that the ISS/TSS ratio for active heterotrophs is almost four times greater than that for 
endogenous decay products.  Thus the measured ISS concentration may have been lower in the AD in 
Phase 2 than in Phase 1 because the active fraction in the AD was lower in Phase 2.  As will be 
presented in section 4.3.2.3, the active fraction in the AD determined from the offline respirometric 
data was 55 ± 13% in Phase 1 and 32 ± 7% in Phase 2.  The difference between these two averages 
was 23% and a t-test at the 95% confidence level showed that this difference was significant.  
     
In summary, the results presented in this section suggested that the AD WAS was entirely comprised 
of Zbh and Ze in Phases 1 and 2.  It appeared that any XSTO present in the WAS fed to the AD was 
depleted in the AD.  The VSS concentration in the AD remained constant during Phases 1 and 2 
which indicated that pretreatment did not alter the biodegradable fraction of the BR WAS.  
Furthermore, the ffCOD concentration in the AD remained constant during Phases 1 and 2 which 
suggested that pretreatment did not generate Sus.  These findings will be used in section 4.3.2.4 and 





4.3 Biological Analyses of Process Streams 
 
4.3.1 Online Respirometry 
 
In the online respirometry in the AD, automatic aeration control was used to allow the DO 
concentration to fluctuate between 3 and 5 ppm, as described in section 3.6.1.  A typical DO 
concentration profile measured in the AD over 3 days is shown in Figure 4.13.  The rate of DO 
decline was calculated for every time period between the high and low DO set points to generate 
OUR values.     
 
Figure 4.13 Typical DO Concentration in AD and OUR Calculation from Rate of DO Decline 
 
The OUR values were plotted with respect to time as shown in Figure 4.14.  Three complete reaction 
periods are visible in Figure 4.14.  The highest OUR values occurred immediately following substrate 
addition when the substrate utilization rate in the digester was highest.  It can also be observed that 
the OUR values became effectively constant at the end of each reaction period, implying that most of 
the substrate was consumed.  The area under the OUR curve during the entire reaction period was 
calculated as the cumulative oxygen uptake (ΣOUt) in the reactor.  The measured OU was entirely 
carbonaceous because the nitrogenous OU was suppressed throughout Phases 1 and 2.  Since the 
length of the reaction periods varied by 2 to 3 hours between days, the average ΣOUt per reaction 




Figure 4.14 Typical OUR in AD  
 
Only one successful online respirometry measurement was made during Phase 1 whereas 12 
successful measurements were obtained during Phase 2.  The limited number of measurements in 
phase 1 was due to challenges associated with the experimental apparatus.  The Jenco© model LD-
900-5-DO Industrial Inline DO Probe used in this project consisted of a gold cathode and silver anode 
submersed in an electrolyte solution.  Oxygen entered the probe through a permeable membrane by 
diffusion and was reduced at the cathode, creating a measurable electrical current.  The Bodine® 
Model 0158 DC Gearmotor used to mix the AD contents imparted a current to the liquid via the shaft 
and this interfered with the DO measurement and control.  Several unsuccessful attempts were made 
to isolate the DC gearmotor.  Hence, accurate ΣOUt measurements were only obtained when this DC 
gearmotor was replaced by an AC motor.  
  
In addition, it was during Phase 1 that it was observed that the anode and cathode of the DO probe 
underwent rapid and extensive fouling while the probe was immersed in the AD and this negatively 
impacted the DO readings.  This fouling may have been caused by the relatively high chloride 
concentration in the AD, originating from the ammonium chloride, ferric chloride, magnesium 
chloride and calcium chloride used in the synthetic wastewater.  A special reconditioning kit was 
ordered from the supplier and used after every respirometry run to restore the gold cathode.  The 
silver anode was cleaned after every test by soaking the probe overnight in 3% ammonium hydroxide 
and then sanding it to remove the tarnish.  Accurate ΣOUt measurements were only obtained when 




The ΣOUt in the AD over the reaction period was assumed to be comprised of two parts: the ΣOU due 
to the endogenous respiration of the AD biomass (ΣOUe) and the ΣOU attributed to the WAS fed to 
the AD (ΣOUs).  The ΣOUs is discussed further here.  In Phase 1, the COD of the BR WAS fed to the 
AD was expected to be essentially comprised of Zbh, Ze and XSTO.  Therefore, the ΣOUs was expected 
to result from growth on XSTO and decay of Zbh.  In Phase 2, the COD of the pretreated BR WAS was 
expected to be comprised of Sbsc, Xsp and Ze.  It was hypothesized that pretreatment would not change 
Ze but would convert XSTO to Sbsc and Zbh to portions of Sbsc and Xsp.  Therefore the ΣOUs  in Phase 2 
was expected to result from growth on Sbsc and Xsp and decay of Zbh.   
   
An analysis of the COD and VSS measurements in the AD showed that the average food to 
microorganism (F/M) ratio was 0.30 ± 0.05 mgCOD/mgVSS throughout Phases 1 and 2.  This was 
low enough to cause a decay-dominated OUR response (Musser, 2009).   Therefore, it was assumed 
that any growth OUR response would be masked by the decay response.  This assumption was 
validated by the results.  The OUR response in the AD shown in Figure 4.14 was measured during 
Phase 2.  However, these curves were typical of the OUR measured in the AD throughout Phases 1 
and 2.  As shown in Figure 4.14, the OUR decreased over the reaction period.  The shape of these 
decreasing OUR curves shows substrate depletion and endogenous respiration but not growth.              
 
To determine the ΣOUs value (mg O2/L) for each online respirometric test, the ΣOUe value was first 
estimated from the offline respirometric tests on the AD WAS.  The endogenous OUR equation 2.4 
proposed by Jones et al. (2009) was modified to eliminate the nitrogenous OUR, producing equation 
4.11. 
       (4.11) 
A nonlinear regression fit of equation 4.11 to the endogenous OUR response measured by offline 
respirometry was used to yield the initial active heterotroph concentration in the AD WAS, as 
described previously in section 2.1.5.1.  Offline respirometry was carried out at 25
o
C hence the value 
of bh,25C was determined using equation 4.12.  The assumed value of bh,20C was 0.24 d
-1
 (Henze et al., 
2008).   
        (4.12)  
Using equation 4.12, the value of bh,25C was calculated to be 0.28 d
-1
.  The results of the offline 
respirometric tests will be presented in the next section however the measured and predicted 
endogenous OUR (OURe) curves obtained on day 264 are shown as an example in Figure 4.15.  This 
curve fit was representative of those obtained for the other measurement events.  
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Figure 4.15 Measured and Predicted Endogenous OUR in AD WAS at 25
o
C   
 
Using the predicted initial active heterotroph concentration, equation 4.11 with bh,20C was then used to 
estimate the endogenous OUR response at 20
o
C in the AD since online respirometry was carried out 
at 20
o
C.  This endogenous OUR response was then plotted together with the total OUR response 
measured by online respirometry on day 264, as shown in Figure 4.16.  These curves are 
representative of those obtained for the other measurement events.  The area under this endogenous 
OUR curve was then used to estimate the ΣOUe value which was then subtracted from the area under 
the total OUR curve (ΣOUt) to yield the ΣOUs value. 
 
  






The online respirometric data was used to determine whether pretreatment changed the overall 
aerobic degradability of the BR WAS.  The ΣOUs value was divided by the measured TCOD 
concentration of the substrate, i.e. the WAS fed to the AD, for every successful test result.  
Calculation of the ΣOUs/TCOD ratio was based upon the mass associated with each response for one 
cycle of operation.  As mentioned in section 3.3.2, 0.6 L of BR WAS was fed to the AD each cycle 
and the AD was 6 L.  Thus the calculated ΣOUs values (mg O2/L) were multiplied by 6 L and the 
corresponding measured TCOD concentrations (mg COD/L) of the substrate were multiplied by 0.6 
L.  
  
The average value of the ΣOUs/TCOD ratio was calculated for Phases 1 and 2.  A significant increase 
in these values between Phase 1 and 2 average would indicate that pretreatment changed the overall 
aerobic biodegradability of the WAS.  The average value of the ΣOUs/TCOD ratio was calculated to 
be 16% in Phase 1 and 15 ± 4% in Phase 2.  A t-test at the 95% confidence level showed that the 
difference between these two averages was insignificant which suggested that pretreatment did not 
change the aerobic degradability of the WAS over the AD reaction period.   
         
 
4.3.2 Offline Respirometry 
 
4.3.2.1 Shape and Magnitude of OUR Curves 
 
Unlike online respirometry, it was expected that the OUR curves generated from offline respirometry 
would show growth responses.  This was because the F/M ratio in the offline respirometric tests on 
bottles containing AD WAS and raw or pretreated BR WAS ranged from 5 to 10 mgCOD/mgVSS 
which was sufficiently high to show a growth response if substrate were present in the bottle.  
     
In Phase 1 it was assumed that the BR WAS consisted of Zbh, Ze and XSTO hence the OUR response in 
bottles containing whole BR WAS was expected to reflect growth on XSTO, depletion of XSTO and 
decay of Zbh.  The SRT in the BR was 5 days whereas it was 10 days in the AD hence the BR WAS 
was expected to have a higher ratio of active organisms to endogenous decay products as compared to 
the AD.  Correspondingly, the OUR (mg O2/L/h) in the BR WAS was expected to be greater than that 




Three offline respirometric tests were run during the first phase of the project, from day 179 to 203, 
with the bottles containing BR WAS only, AD WAS only and BR WAS that was inoculated with AD 
WAS.  Only the second and third tests produced useful data as residual rbCOD from the synthetic 
wastewater was present in the first test that was run on day 175.  This test was conducted just before 
the synthetic feed concentration was halved.  Figure 4.17 shows a typical OUR response in the bottles 
of the two successful tests.   
 
Figure 4.17 Typical Phase 1 OUR in BR WAS, AD WAS and Inoculated BR WAS 
 
In the bottle containing AD WAS, the OUR decreased exponentially with time.  This was the 
expected response for a sludge that consumes oxygen through endogenous respiration alone.  In the 
bottles containing BR WAS only and inoculated BR WAS, the OUR decreased for the first 5 hours of 
the test, then increased, peaked and finally decreased exponentially with time.  The magnitude of 
these two curves during the first 5 hours was more than twice that of the AD WAS curve.  This was 
expected because the BR was assumed to contain a higher active fraction than the AD.  The peak in 
the OUR curves for BR WAS and inoculated BR WAS suggested biomass growth.  Furthermore, 
because the peaks were observed in these two responses but absent in the AD WAS response, the 
substrate for this biomass growth was assumed to be present in the BR WAS alone.  As previously 
mentioned, the BR WAS used in the offline respirometry test was taken from the BR at the end of the 
reaction period, long after the synthetic substrate had been consumed.  Hence the apparent growth 
was not due to the synthetic substrate.  The observed OUR responses were therefore consistent with 
the previously stated hypothesis that the BR WAS contained XSTO in addition to Zbh and Ze.  This 
hypothesis was supported by the previously described low average COD/VSS ratio of 1.25 in the BR 
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WAS; a low average pON/PCOD ratio of 0.05 in the BR WAS; and the observed generation of Sus in 
the AD.  It appeared that XSTO was consumed during the batch respirometry and exerted an oxygen 
demand that was different than that which would be attributed to endogenous respiration. 
 
In Phase 2, offline respirometric tests were run on bottles containing pretreated BR WAS only, AD 
WAS only and pretreated BR WAS inoculated with AD WAS.  Once the feed to the AD was 
switched from raw to pretreated BR WAS on day 203, one offline respirometric test was carried out 
every week for 9 weeks.  Due to power failures, two of these tests did not run until the endogenous 
OUR response was clearly visible and thus the data could not be used.  Three tests were run when the 
AD WAS was not acclimatized to the pretreated BR WAS.  Only one of these three tests produced 
usable data as there were various sources of error in the other tests.  These error sources included 
restricted oxygen flow through the tubing and needles, leaks in the bottle caps and water collection in 
the oxygen supply lines. The set of OUR curves generated in the successful offline respirometric tests 
on pretreated BR WAS and the associated AD WAS are presented in Appendix C. 
 
Overall, there was no distinguishable difference in the shape of the OUR curves from the inoculated 
bottles in either the non-acclimatized test or the progressively acclimatized tests.  The differences in 
the areas under these curves will be discussed in section 4.3.2.2. 
 
In Phase 2 it was expected that the OUR response in the bottles containing pretreated BR WAS and 
AD WAS would result from both growth and decay since pretreatment was expected to convert 
portions of the TCOD of the BR WAS to Sbsc and Xsp.  As shown in section 4.2.3, pretreatment 
increased the SCOD concentration by 56%.  Since it was also shown in section 4.2.4 that pretreatment 
did not generate Sus, the SCOD generated by pretreatment was expected to be Sbsc.  Similar to Phase 
1, the OUR responses in bottles containing AD WAS were expected to show only decay.  
    
Figure 4.18 shows typical OUR responses in the bottles during Phase 2 of the project.  The labels PT, 
AD and PT + AD represent the respective OUR curves for pretreated BR WAS, AD WAS and 
pretreated BR WAS inoculated with AD WAS.  This graph is representative of the eight successful 
offline respirometric tests involving pretreated BR WAS and the associated AD WAS.  In the bottles 
containing only AD WAS, the OUR decreased exponentially with time as expected.  At any given 
time during the respirometry test, the height of this curve was always less than that of the Phase 1 AD 
WAS, indicating that the active fraction was lower in the AD in Phase 2 than in Phase 1.  The bottles 
containing only pretreated BR WAS exerted oxygen uptake, indicating viable cells remained in the 
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sludge after pretreatment.  Estimates of the heterotroph concentrations will be presented in section 
4.3.2.3.  The OUR curve for pretreated BR WAS showed a peak between 60 and 70 hours, suggesting 
delayed biomass growth.  However, the area under this peak comprised only 5% of the total area 
under the curve.  Therefore, this delayed peak was considered negligible.   
          
Figure 4.18 Typical Phase 2 OUR in Pretreated BR WAS, AD WAS and Inoculated Pretreated BR WAS 
 
Comparing Figures 4.17 and 4.18, the OUR curve for the inoculated pretreated BR WAS peaked 
earlier and to a higher value than the OUR curve for the inoculated raw BR WAS.  This response is 
characteristic of growth on rbCOD.   
 
For each successful respirometry run, the mass OUR curves (mg O2/h) were plotted by multiplying 
the measured OUR concentration (mg O2/L/h) by the volume of WAS in the bottle.  The endogenous 
OUR curve was subtracted from the OUR curve of the inoculated bottle to yield the OUR response of 
the substrate only.  This approach was carried out for both the whole and filtered substrate.  The 
substrate OUR responses from the offline respirometric tests on pretreated BR WAS and associated 
AD WAS were compared to the substrate OUR responses from the tests on BR WAS and associated 
AD WAS.  The OUR responses of the whole and filtered pretreated BR WAS substrates were found 
to be reproducible as were those of the whole and filtered BR WAS substrates.  Therefore, the OUR 
responses of the whole and filtered pretreated BR WAS substrates (Phase 2) were compared to the 




Figure 4.19 Comparison of Typical Substrate OUR in Phases 1 and 2  
 
From Figure 4.19 it can be seen that the OUR in the filtered BR WAS was negligible, indicating the 
absence of soluble biodegradable COD.  The biodegradable COD of the BR WAS was thus entirely 
particulate.  This was expected because filtration removed the only two components in the BR WAS 
that were assumed to exert an oxygen demand, i.e. Zbh and XSTO.  In contrast, the area under the OUR 
curve for the filtered pretreated WAS contributed more than 60% of the area under the whole 
pretreated WAS curve which demonstrates that pretreatment substantially solubilized biodegradable 
COD.   
 
 
4.3.2.2 Extent of Aerobic Biodegradability 
 
Similar to online respirometry, offline respirometry was used to determine whether pretreatment 
changed the overall aerobic degradability of the BR WAS.  The cumulative oxygen uptake (mg O2) 
associated with the substrate during every successful offline respirometric test was divided by the 
measured TCOD (mg COD) of the substrate at the beginning of the test.  The average value of this 
ratio was calculated for the raw BR WAS and pretreated BR WAS.  A significant difference between 
these average ratios would indicate that pretreatment changed the overall aerobic biodegradability of 
the WAS.  This ratio was only determined for the whole substrate because it was shown that the 
SCOD concentration in the BR WAS was negligible.  Hence the cumulative oxygen uptake and 




The cumulative oxygen uptake (mg O2) associated with the substrate was calculated in two separate 
ways using the offline respirometric data.  The first approach relied on the measured mass of TCOD 
in the respirometry bottle at the beginning and end of the test whereas the second approach employed 
the mass of gas phase oxygen measured by the respirometer during the test.   
 
In the first approach, the difference between the initial and final mass of TCOD in each bottle 
(TCODi – TCODf) was calculated for each offline respirometric test.  The mass of TCOD in the bottle 
was determined by multiplying the measured TCOD concentration (mg COD/L) in the bottle by the 
volume of liquid in the bottle.  The (TCODi – TCODf) value for the substrate was then determined by 
subtracting the (TCODi – TCODf) value in the bottle containing only AD WAS from the (TCODi – 
TCODf) value in the bottle containing AD WAS and raw or pretreated BR WAS.  
  
The biodegradability of the substrate was then assessed by dividing the (TCODi – TCODf) value for 
the substrate by the initial TCOD of the substrate in the bottle for each respirometry run, as shown in 
Figure 4.20.  A significant difference between the average (TCODi – TCODf)/TCODi ratios for raw 
BR WAS and pretreated BR WAS would indicate that pretreatment changed the overall aerobic 
biodegradability of the WAS.  Because the BR WAS was shown to remain stable throughout Phases 1 
and 2, the only factor that could cause a change in the overall aerobic biodegradability of the BR 
WAS would be pretreatment.   
 
 
Figure 4.20 (TCODi – TCODf)/TCODi Ratio from Offline Respirometry on Substrate 
 
Using the data presented in Figure 4.20, the average (TCODi – TCODf)/TCODi values were 46 ± 15% 
for the BR WAS, 78% for the pretreated BR WAS with non-acclimatized inoculum and 59 ± 11% for 
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the pretreated BR WAS with acclimatized inoculum.  A t-test at the 95% confidence level showed 
that the average (TCODi – TCODf)/TCODi ratio for BR WAS was equivalent to the average ratio for 
pretreated BR WAS with acclimatized inoculum, indicating that pretreatment did not change the 
fraction of the BR WAS that could be degraded by acclimatized inoculum.  This finding corroborated 
the results of the online respirometric tests and supported the finding that the VSS concentration in 
the AD remained constant during Phases 1 and 2.  Considering the seven data points for the 
acclimatized pretreated (TCODi – TCODf)/TCODi ratio in Figure 4.20, the last four data points had 
an average and standard deviation of 56 ± 1%, which showed very low variability.  The stability of 
these last four measurements indicated that the AD biomass had acclimatized to the pretreated feed.   
      
Based on the data presented in Figure 4.20, the (TCODi – TCODf)/TCODi ratio for pretreated BR 
WAS with non-acclimatized inoculum was 32% higher than the average ratio for BR WAS and a t-
test at the 95% confidence level showed that this difference was significant.  This suggested that 
pretreatment increased the fraction of the BR WAS that could be degraded by non-acclimatized 
inoculum.  However, because there was only one valid measurement of pretreated BR WAS with 
non-acclimatized inoculum, additional experiments should be carried out to further investigate this 
trend.  By comparison, Kianmehr (2010) found that with WAS pretreated with ozone, the 
biodegradable fraction determined by offline respirometry was higher using an acclimatized inoculum 
than a non-acclimatized inoculum.  However, Kianmehr (2010) also demonstrated that it was 
unnecessary to acclimatize the inoculum when using sonication pretreatment.  Further studies should 
be carried out to determine the impact of biomass adaptation on the degradation of WAS pretreated 
by HPTH.  
  
The second approach to estimate the aerobic biodegradability from the offline respirometry employed 
gas phase oxygen consumption to estimate the cumulative oxygen uptake (mg O2) associated with the 
substrate.  In these cases, the ΣOUs value (mg O2) for each offline respirometric test was determined 
by subtracting the measured ΣOU in the sample bottles containing only AD WAS (ΣOUe) from the 
ΣOU value in the inoculated bottle (ΣOUt).  The ΣOUs value was then corrected for the mass of 
oxygen required to reach liquid saturation in the bottle since the DO concentration was effectively 
zero at the beginning of the respirometry test.  In addition, the ΣOUs value was corrected for the mass 
of oxygen manually drawn into the bottle using a syringe in the air-tightness test performed at the 
start of the run.  The biodegradability of the substrate was then assessed by dividing the ΣOUs value 
for the substrate by the measured initial mass of TCOD of the substrate for each respirometry run, as 




Figure 4.21 ΣOUs/TCODi Ratio from Offline Respirometry on Substrate 
 
Overall, the trends in Figure 4.21 were similar to those in Figure 4.20 in terms of the relative 
magnitude of the ratios among the different types of substrate.  The average ΣOUs/TCODi values 
were calculated for the BR WAS, pretreated WAS with non-acclimatized inoculum and pretreated 
WAS with acclimatized inoculum.  It was found that each of these average values was higher than the 
respective average value calculated using the measured initial and final TCOD concentrations in the 
sample bottle.  Because the (TCODi – TCODf)/TCODi ratio in the first approach relied on only one 
measurement technique whereas the ΣOUs/TCODi ratio in the second approach involved two 
techniques, there may have been a higher level of error associated with the second approach than with 
the first.  The potential sources of error are discussed subsequently. 
 
The accuracy of the TCOD measurements was verified in several ways.  Every day the TCOD 
concentrations in the respirometry bottle were measured, blank and standard samples were also tested.  
The measured concentrations of the blanks and standards were significantly close to the expected 
values.  In addition, on day 203 and 250, four replicate samples were taken from a randomly selected 
respirometry bottle and a COD standard was added to half of these replicates.  The average measured 
TCOD of the two replicates containing only sample was subtracted from that of the replicates 
containing standard and sample in order to calculate the TCOD of the standard.  There was no 
significant difference between the calculated value of the standard and the directly measured value.  
Therefore, the measured TCOD concentrations in the offline respirometry bottles at the beginning and 




The TCOD closure error was calculated according to equation 4.13 for the bottles containing AD 
WAS only, substrate only and inoculated substrate in every successful batch respirometry test.  In this 
equation, the cumulative oxygen uptake (mg O2) in the bottle calculated by the first approach (TCODi 
– TCODf) was subtracted from that calculated by the second approach that employed the gas phase 
oxygen consumption (ΣOU).  This difference was then divided by the measured mass of TCOD in the 
bottle at the end of the test (TCODf) and expressed as a percentage.   
    (4.13) 
The cumulative oxygen uptake calculated on the basis of oxygen consumption was consistently 
higher than that calculated by COD removal; hence the TCOD closure error was consistently positive.  
The average TCOD closure error for bottles containing only AD WAS was found to be 5 ± 2%, which 
was relatively low.  By comparison, the TCOD closure error ranged from 10 to 35% in the other 
bottles.  As expected, the cumulative oxygen uptake in bottles containing AD WAS was consistently 
lower than the cumulative oxygen uptake in bottles containing either substrate or inoculated substrate.  
The higher TCOD closure errors would therefore appear to be associated with the higher oxygen 
demands.  Since the TCOD measurements were believed to be accurate, this positive closure error 
indicated that the offline respirometric tests overestimated the oxygen uptake in the bottles.  As a 
result, the ΣOUs/TCODi ratio was probably less accurate than the (TCODi – TCODf)/TCODi ratio.  
Therefore, the assessment of the impact of pretreatment on the overall aerobic biodegradability of the 
BR WAS was based on the comparison of the average (TCODi – TCODf)/TCODi ratios rather than a 
comparison of the average ΣOUs/TCODi ratios. 
 
As presented in section 4.3.1, the average ΣOUs/TCODi ratio determined by online respirometry was 
16% for BR WAS and 15 ± 4% for pretreated BR WAS.  By comparison, the average (TCODi – 
TCODf)/TCODi ratio determined by offline respirometry was 46 ± 15% for BR WAS and 59 ± 11% 
for pretreated BR WAS with acclimatized inoculum.  Thus the average (TCODi – TCODf)/TCODi 
ratios determined by offline respirometry for BR WAS and pretreated BR WAS with acclimatized 
inoculum were 30% and 44% higher, respectively, than the corresponding ratios determined by online 
respirometry.  T-tests at the 95% confidence level showed that both of these differences were 
significant.  It was hypothesized that the online respirometric measurements underestimated the 
cumulative oxygen uptake over the reaction period because these measurements failed to capture 
rapid and high oxygen uptake.  In Phases 1 and 2, delays of 30 to 60 minutes were observed in raising 
the DO concentration from the low to high set-points during the period immediately after the AD was 
fed.  These delays were presumably due to insufficient aeration in the AD.  In addition, the differing 
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methodologies of the two respirometric tests may have further contributed to generating (TCODi – 
TCODf)/TCODi ratios from offline respirometry that were significantly higher than the magnitudes of 
the ΣOUs/TCODi ratios from online respirometry.  The offline respirometric tests were run for 4 to 5 
days at an F/M ratio of 5 to 10 mgCOD/mgVSS.  By contrast, the online respirometric tests measured 
the ΣOU in the AD over the reaction period of 22 hours and the average F/M ratio in the AD was 0.30 
± 0.05 mgCOD/mgVSS.   
 
In summary, the offline respirometric results showed that pretreatment did not change the overall 
aerobic biodegradability of the BR WAS.  It was previously shown in section 4.2.3 that pretreatment 
also did not change the TCOD of the BR WAS.  Therefore, it was hypothesized that the concentration 
of non-biodegradable COD in the pretreated BR WAS was equivalent to that in the raw BR WAS.  
This non-biodegradable COD was assumed to be comprised of only Ze since the Sus concentration in 
the BR WAS was negligible and Sus was not generated by pretreatment.  Thus the concentration of 
bCOD in the BR WAS was assumed to be equivalent to that in the pretreated BR WAS.  The bCOD 
of the BR WAS was shown to be comprised of Zbh and XSTO.  It was hypothesized that the bCOD of 
the pretreated BR WAS was comprised of Sbsc and Xsp.  This hypothesis was based on the shape and 
magnitude of the OUR curves generated by offline respirometry and the measured increase in SCOD 
concentration caused by pretreatment.  It was not possible to use the approach proposed by Kianmehr 
(2010) to quantify the Sbsc concentration in the pretreated BR WAS using the offline respirometric 
data.  The F/M ratio was high in the tests employed in the current study hence significant growth 
occurred in bottles believed to contain Sbsc.  The peaks due to growth were high and extended and 
multiple successive peaks were typically observed.   The area under the OUR curve was thus a 
complex function of cell growth, decay and the oxidation of Sbsc and Xsp.  Instead, the Sbsc and Xsp 
concentrations in the pretreated BR WAS were estimated by fitting OUR responses predicted by 
activated sludge models to the measured offline respirometric data.  This approach will be presented 
in section 5. 
 
 
4.3.2.3 Active and Endogenous COD Fractions 
 
This section presents the results of an analysis of the offline respirometric data that estimated the 
concentrations of Zbh and Ze in the WAS samples.  These estimated concentrations were compared to 
the measured TCOD concentration of the WAS to determine the active and endogenous COD 
fractions.  The estimation of Zbh and Ze in the BR WAS is presented first.  The XSTO concentration 
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was then estimated by subtracting the sum of Zbh and Ze from the TCOD of the BR WAS.  Estimates 
of the active and endogenous COD fractions in the pretreated BR WAS are subsequently presented.  
Lastly, the estimation of the active fractions in the AD and corresponding endogenous fractions 
during Phases 1 and 2 are presented.   
 
The literature review presented in section 2.1.5.1 discussed two methods to estimate the active 
fraction of the BR WAS.  However, in this study, the OUR response measured in batch respirometry 
bottles containing only BR WAS showed both decay and growth and hence the active fraction could 
not be determined by fitting the endogenous OUR equation 2.4.  The results suggested that in these 
batch tests, the stored COD in the BR WAS was used to generate new biomass.  Hence, the 
concentration of active heterotrophs in the BR WAS was determined by the offline respirometric test 
carried out on day 278 on sample bottles containing BR WAS and synthetic feed in high F/M ratios.   
 
Figure 4.22a presents a typical respirogram obtained from this test and Figure 4.22b shows the 
exponential growth portion of the curve.  Using the data from Figure 4.22b, ln(OUR) versus time was 
plotted in Figure 4.22c.  The active heterotroph concentration in the sample bottles (Zbh0) was 
determined by equation 2.3 using the slope and y-intercept from the plot of Figure 4.22c and 
assuming typical values for Yh and bh.  These three graphs were plotted for each sample bottle and the 
active heterotroph concentration in each bottle was calculated.  For each bottle, the concentration 
obtained using equation 2.3 was then multiplied by the dilution factor in the bottle to estimate the 






Figure 4.22 Typical Respirometry Data Used to Estimate Zbh,0 (a) Total Respirogram (b) Exponentially 
Increasing Portion of Respirogram (c) Log of Exponentially Increasing Portion 
 
The average concentration of active heterotrophs in the BR WAS was estimated to be 2133 ± 73 mg 
COD/L.  As reported in section 4.2.2, the average TCOD concentration in the BR WAS was 4170 ± 
324 mg/L.  Therefore the average active fraction of the BR WAS was 51 ± 4%.  This was 17% lower 
than the active fraction reported by Ramdani et al. (2012) who operated an MBR with a 5.2 day SRT 
fed with sodium acetate as the sole carbon source.  The active fraction was expected to be lower in 
the BR WAS because a portion of the biodegradable synthetic substrate was believed to be stored 
inside the cells in the BR WAS whereas the WAS employed by Ramdani et al. (2012) did not contain 




The concentration of endogenous decay products was determined by the endogenous respiration 
approach:   
  (Parker, 2010)    (4.14) 




C and f = 0.2.  The dataset of concentrations estimated for the active 
heterotrophs as per equation 2.3 was substituted into equation 4.14 to generate a dataset of 
concentrations for the endogenous decay products.  The average COD concentration of endogenous 
products in the BR WAS was 512 ± 17 mg/L and the average endogenous COD fraction was 12 ± 
1%.  This was 20% lower than the endogenous fraction reported by Ramdani et al. (2012) who 
operated a similar system.  The lower fraction was expected because the BR WAS contained stored 
COD whereas the WAS used by these authors did not.  The presence of stored COD would result in 
less grown biomass and hence less decay of biomass to produce Ze.  The measured ffCOD in the BR 
WAS was 53 ± 12 mg COD/L which was only 1% of the TCOD.  Thus the soluble non-biodegradable 
COD fraction was considered negligible.  The sum of the active and endogenous COD fractions was 
63 ± 4% hence the remaining 37 ± 4% was assumed to be stored COD.  This estimate of fSTO was 
comparable to the estimate derived from the measured pON/PCOD value (fSTO = 25 ± 9%) and the 
estimate derived from the measured COD/VSS ratio (fSTO = 54 ± 28%).   
 
Based on the literature review of HPTH pretreatment studies, it was expected that pretreatment would 
substantially if not completely inactivate the heterotroph population in the WAS.  In this study, the 
active fraction was determined from the OUR response in the sample bottles containing only 
pretreated BR WAS.  The Zbh0 concentration in the sample bottles containing pretreated BR WAS 
was determined by plotting ln(OUR) versus time for the exponentially increasing portion of the 
measured OUR curve and fitting equation 2.3 with typical values for Yh and bh.  The Zbh0 
concentration was then multiplied by the dilution factor in the bottle to determine the concentration of 
active heterotrophs in the pretreated BR WAS (Zbh,PT).  The active fraction in the pretreated BR WAS 
was consistently found to be less than 5%.  For the purpose of fractionating the COD, it was therefore 
assumed that pretreatment fully inactivated the biomass.  
    
The constant measured VSS concentration in the AD during Phases 1 and 2 and the results of the 
online and offline respirometric tests showed that the biodegradable COD fraction (bCOD) of the 
WAS was unchanged by pretreatment with an acclimatized biomass.  It was therefore assumed that 
none of the endogenous residue was converted to biodegradable COD by pretreatment.  Since the 
TCOD of the WAS was unchanged by pretreatment, the endogenous fraction of the pretreated WAS 
was assumed to be equivalent to that of the BR WAS, i.e. 12 ± 1%.   
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The concentration of active heterotrophs in the bottles containing AD WAS was determined by fitting 
equation 2.4 by nonlinear regression to the measured OUR in these bottles.  This concentration was 
then multiplied by the dilution factor in the bottle to estimate the concentration of active heterotrophs 
in the AD WAS (Zbh,AD).  It is believed that this approach was valid because the measured OUR 
response was typical of that associated with endogenous decay.  The concentration of active 
heterotrophs in the steady-state AD was found to be 1200 ± 260 mg COD/L in Phase 1 and 700 ± 150 
mg COD/L in Phase 2.  The average TCOD of the AD WAS throughout the project was 2174 ± 188 
mg COD/L hence the average active fraction was 55 ± 13% in Phase 1 and 32 ± 7% in Phase 2.  A t-
test at the 95% confidence level showed no significant difference between the average active fraction 
in the BR WAS and that in the Phase 1 AD WAS.  It was expected that the active fraction of the AD 
WAS would be less than that of the BR WAS in Phase 1 without pretreatment.  However, unlike the 
BR WAS, the AD WAS did not contain stored COD as:  the measured COD/VSS ratio of the AD 
WAS was typical of that for active biomass and decay products; and the OUR response in the AD 
WAS showed only an endogenous decay response.  Therefore, it is believed that the biomass in the 
AD oxidized the storage products present in the BR WAS for energy production and cell synthesis.  
The active fraction in the AD WAS was therefore comprised of active biomass from the BR WAS 
that was undergoing endogenous decay in the digester and new biomass that grew in the digester on 
the storage products contained in the BR WAS.  This would explain the higher than expected active 
fraction of the AD WAS in Phase 1.  
    
The endogenous residue in the AD was assumed to consist of the sum of that originating from the BR 
WAS and that generated in the AD and was estimated using equation 4.15:   
       (4.15) 




C and f = 0.2.  The concentrations estimated for the active heterotrophs in 
the AD in Phases 1 and 2 were substituted into equation 4.15 to generate corresponding values for the 
concentrations of the endogenous decay products.  The average Ze,AD value in Phase 1 was estimated 
to be 1090 ± 350 mg COD/L and hence the endogenous COD fraction was estimated to be 50 ± 17%.  
In Phase 2, the Ze,AD value was estimated to be 850 ± 270 mg COD/L and the endogenous COD 
fraction was estimated to be 39 ± 13%.  The active and endogenous COD fractions in the BR, 






4.3.2.4 COD Fractionation of the WAS  
 
Figure 4.23 summarizes the COD fractions in each sludge stream that could be estimated from the 
compiled results of the conventional analyses and offline respirometric tests.  Only significant COD 
fractions are shown.  The sludge streams included the BR WAS, pretreated BR WAS, AD WAS 
treating raw BR WAS (Phase 1) and AD WAS treating pretreated BR WAS (Phase 2).  The COD 
fractions presented in Figure 4.23 were also estimated by simulating the entire system with calibrated 
activated sludge models and this will be discussed further in chapter 5.   
 
Figure 4.23 COD Fractionation of Sludge Streams  
 
The BR WAS was comprised of Zbh, Ze and XSTO.  As described in section 4.3.2.3, the COD fractions 
attributed to Zbh and Ze were estimated to be 51 ± 4% and 12 ± 1%, respectively, based on analyses of 
the offline respirometric data.  The stored COD fraction, fSTO, was estimated in three different ways: 
using the COD/VSS ratios (fSTO = 54 ± 28%); using the pON/PCOD ratios (fSTO = 25 ± 9%); and 
using the COD not attributed to active and endogenous fractions determined by offline respirometry 
(fSTO = 37 ± 4%).  As discussed in section 4.2.3, the first approach was probably less accurate than the 
second because only one value was assumed in the first whereas two values were assumed in the 
second.  A t-test at the 95% confidence level showed that the fSTO estimates from the second and third 
approaches differed significantly.  However, this difference was only 12% which was considered 
relatively small.  Hence, for the purpose of COD closure, the COD fraction attributed to XSTO was 
assumed to be 37 ± 4% in Figure 4.23.  The BR WAS contained an average measured ffCOD 
concentration of 53 ± 12 mg/L which was assumed to be Sus from SMPs.  This fraction comprised 
only 1.3 ± 0.3% of the TCOD of the BR WAS hence it was considered negligible in the overall COD 
fractionation presented in Figure 4.23.  
   
The pretreated BR WAS was assumed to be comprised of Sbsc, Xsp and Ze.  It was shown that 
pretreatment did not change the TCOD of the BR WAS nor did it change the biodegradable fraction.  
Therefore the endogenous fraction in the pretreated BR WAS was assumed to be equivalent to that in 
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the BR WAS, i.e. 12 ± 1%.  It was assumed that XSTO and Zbh in the BR WAS were converted to a 
mixture of Sbsc and Xsp in the pretreated BR WAS.  As shown in section 4.2.3, pretreatment increased 
the average SCOD concentration in the BR WAS from 1% to 57%.  Since it was shown in section 
4.2.4 that pretreatment did not generate Sus, the SCOD generated by pretreatment was expected to be 
Sbsc.  Because this Sbsc generated by pretreatment was significantly higher than the XSTO estimated to 
be present in the BR WAS, it was assumed that XSTO had been fully converted to Sbsc.  The storage 
products were assumed to be released when the cells were inactivated by pretreatment.  The balance 
of Sbsc not originating from XSTO was assumed to originate from Zbh.  The portion of Zbh not converted 
to Sbsc was assumed to be converted to Xsp.  The Sbsc and Xsp concentrations in the pretreated BR 
WAS were estimated by fitting OUR responses predicted by activated sludge models to the measured 
offline respirometric data.  This work will be presented in chapter 5.  
 
The AD WAS was comprised of Sus, Zbh and Ze in Phases 1 and 2.  The Sus was believed to be 
generated by the decay of cells that stored COD.  As shown in section 4.2.4, the average measured 
ffCOD concentration in the AD WAS was 190 ± 11 mg COD/L in Phase 1 and 177 ± 31 mg COD/L 
in Phase 2.  Thus the average Sus fraction was 9 ± 1% in Phase 1 and 8 ± 2% in Phase 2.  Both of 
these fractions are substantial and were therefore included in the overall fractionation of the AD WAS 
presented in Figure 4.23.  The sum of the average calculated Sus, Zbh and Ze concentrations in the 
Phase 1 AD WAS was 2480 ± 436 mg/L and a t-test at the 95% confidence level showed no 
significant difference between this sum and the average measured TCOD of the Phase 1 AD WAS.  
This mass balance closure suggested that the active and endogenous fractions were well estimated.  
However, the sum of the average calculated Sus, Zbh and Ze concentrations in the Phase 2 AD WAS 
was 1727 ± 310 mg/L which was 447 mg/L less than the average measured TCOD of the Phase 2 AD 
WAS.  A t-test at the 95% confidence level showed that this difference was significant.  This lack of 
mass balance closure may have been due to inaccuracies in the respirometric measurements, error in 
the nonlinear regression fit of equation 2.4 to the respirometric data or inaccuracies in the parameter 
estimates for bh, f and Yh.  As will be discussed in sections 5.2 and 5.3, the COD fractions in the 
various sludge streams were also estimated using calibrated activated sludge models thus the COD 
fractionation of the Phase 2 AD WAS will be revisited.  
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5. Development of the Pretreatment Model 
 
The results of the conventional analyses and respirometric tests were previously used to fractionate 
the COD of the various sludge streams in order to identify the COD transformations caused by 
pretreatment.  It was concluded that pretreatment did not alter the aerobically biodegradable fraction 
of the BR WAS.  However, the results of the batch respirometric tests indicated that pretreatment 
increased the rate of aerobic degradation.  The experimental results presented in section 4 could not 
be directly used to quantify the concentrations of Sbsc and Xsp in the pretreated BR WAS.  In this 
chapter these concentrations will be estimated using activated sludge models.  Furthermore, modeling 
was employed to verify the COD fractions in the various sludge streams that were estimated from the 
results presented in section 4.  An overview of the modeling procedure is discussed first.  
  
The Phase 1 system was simulated using two different models, the BioWin 3.1® Integrated Sludge 
Model and the ASM3 Model.  The models were initially calibrated by systematically adjusting key 
kinetic and stoichiometric parameters within their typical ranges such that the predicted 
concentrations of particulate COD species in the BR and AD WAS were statistically equivalent to the 
respective average measured concentrations.  The accuracy of the parameter estimates was then 
improved by minimizing the sum of squared differences between the predicted and measured OUR 
responses from offline respirometry on BR WAS.  The calibrated model that best fit the measured 
data was then employed to simulate the Phase 2 system.  The concentrations of Sbsc and Xsp in the 
pretreated BR WAS were adjusted such that the predicted concentrations of PCOD and SCOD in the 
pretreated BR WAS and PCOD in the Phase 2 AD WAS were statistically equivalent to the respective 
average measured concentrations.  The accuracy of the estimated Sbsc and Xsp concentrations was then 
improved using a least squares regression between the predicted and measured OUR responses from 
offline respirometry on inoculated pretreated BR WAS.  Once the Sbsc and Xsp concentrations had 
been estimated, the COD fractionation of the pretreated BR WAS was complete.  A COD-based 
stoichiometric pretreatment model was then developed for the dose of HPTH pretreatment employed 
in this study.  This model was evaluated and its limitations were identified.     
 




5.1 Modeling Approach   
 
This section describes the approach taken to simulate the startup and operation of the BR-AD system 
using two different activated sludge models.  An overview of the operation of the reactors throughout 
the project is first discussed.  As described in section 4.1, the BR was operated as an SBR with an 
SRT of 5 d.  The BR was initially seeded with activated sludge and then fed daily with a synthetic 
wastewater.  The concentrations of alkalinity and inorganic nutrients in the synthetic wastewater were 
specified according to the theoretical composition.  The TCOD and COD fractionation of the 
synthetic wastewater were estimated based on COD measurements and required some assumptions.  
On day 20, the AD was started up by being filled with 2 L of BR WAS per day until it contained 6 L.  
The AD continued to be fed daily with BR WAS until the end of the project.  The AD was initially 
operated as an SBR with an HRT of 3 d and an SRT of 10 d.  On day 77, the operation of the AD was 
simplified so that the HRT and SRT were both 10 d.  The concentration of the synthetic wastewater 
fed to the BR was halved on day 179 and this feed concentration was maintained until the end of the 
project on day 283.  The focus period of the project consisted of two phases: Phase 1 from day 179 to 
203 when the AD was fed with raw BR WAS; and Phase 2 from day 203 to 283 when the AD was fed 
with pretreated BR WAS. 
   
The startup and operation of the BR-AD system was simulated using the BioWin 3.1® Integrated 
Model in the BioWin® platform.  The system was simulated exactly as it was operated from day 0 to 
283.  The change in the operation of the AD implemented on day 77 and the change in the 
concentration of the synthetic wastewater implemented on 179 were included in the simulation and it 
was predicted that a new steady state condition would be reached following each change.  The results 
of the conventional analyses confirmed this prediction.  As discussed in section 4.2.2, the 
concentrations of COD and SS species measured by conventional analyses remained relatively stable 
from day 197 until day 283, indicating that the BR was at steady state during this period.  The 
concentrations of TCOD, SCOD, ffCOD and VSS measured in the AD during this period also 
remained relatively constant, showing that the AD was at steady state as well.   
  
It was hypothesized that the steady-state conditions of the Phase 1 BR-AD system only depended on 
the operating conditions and synthetic wastewater recipe employed during this phase.  This 
assumption was tested using a separate, simplified simulation in which the BR was seeded with a 
typical activated sludge, fed synthetic wastewater with the composition used from day 179 onwards 
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and then allowed to reach steady-state.  The AD was then started up and operated as it had been 
during Phase 1, until it stabilized.   The steady-state compositions of the sludge streams in this 
simplified simulation were found to be equivalent to the compositions of the respective sludge 
streams in the Phase 1 steady-state system achieved by modeling the actual operation from day 0.  
The simplified approach was therefore deemed adequate to model the Phase 1 BR-AD system. 
   
In addition to the BioWin 3.1® Integrated Model, the Phase 1 BR-AD system was also modeled with 
the ASM3 Model in the BioWin® platform.   Although the BioWin 3.1® Integrated Model is more 
complex and more widely used than the ASM3 Model, it does not include processes for the storage of 
COD by ordinary heterotrophic biomass that does not accumulate phosphorus (Zbh).  The results 
presented in section 4 showed that the BR WAS contained stored COD in addition to active 
heterotrophs and decay products.  In the ASM3 Model, all readily biodegradable substrate is first 
stored inside cells before it is used for growth and endogenous respiration.  It was therefore 
hypothesized that the ASM3 Model would be well suited for this project.     
 
The configuration of the Phase 1 BR-AD system used in the BioWin® platform is shown in Figure 
5.1.  The overall system was simulated at 20
o
C as this was the average temperature at which the BR 
and AD were operated.  In the simulations, the concentrations of the COD, SS and nitrogen species 
were monitored in each sludge stream so that the predicted steady-state concentrations could be 
compared with the average measured concentrations.  In addition, the OUR in the simulated AD was 
monitored so that it could be compared to the online respirometric results.   
 
In order to simulate the batch respirometric tests, a variable volume reactor labeled “OUR Test” was 
included in the configuration in Figure 5.1.  This reactor was simulated at 25
o
C because the offline 
respirometric tests were operated at this temperature.  Once the BR-AD system was at steady-state, 
150 mL of WAS from the BR was fed to the OUR Test reactor and the simulation was continued for a 
number of days.  The DO concentration in the simulated batch reactor was held constant at 2 mg/L 
and the OUR in this reactor was monitored over time.  Offline respirometry simulations were also 
carried out using 50 mL AD WAS only and a mixture of 150 mL of BR WAS and 50 mL of AD 




Figure 5.1 Configuration of Phase 1 BR-AD System in BioWin® 3.1 Platform 
 
It was shown in sections 4.2.2 and 4.2.4 that the WAS from the BR and AD contained concentrations 
of ffCOD and this was assumed to be Sus from SMPs generated in the reactors.  A significantly higher 
average concentration of Sus was measured in AD WAS than in the BR WAS which suggested that 
the SMPs were generated by endogenous decay rather than by growth.  Neither the BioWin 3.1® 
Integrated Model nor the ASM3 Model predicts the channeling of COD into SMPs for processes 
involving Zbh.  Therefore, the simulated synthetic wastewater was assigned a Sus concentration 
equivalent to the average measured ffCOD concentration in the BR WAS.  No provision was made to 
simulate the additional Sus shown to be generated in the AD hence it was expected that both models 
would underestimate the ffCOD and SCOD concentrations in the AD. 
 
During the focus period of the project, the nitrate concentrations measured in the BR and AD were 
consistently below 1 mg N/L, indicating that nitrification was negligible in both reactors.  In order to 
simulate this response, the value of the maximum specific growth rate of the ammonia oxidizing 
biomass (μa) in both the BioWin 3.1® Integrated Model and ASM3 Model was set to zero.  Besides 
this parameter, the kinetic and stoichiometric parameters employed in each model differed 
considerably and will therefore be discussed separately in the next two sections.  An overview of the 
capabilities of each model will also be presented.  
 
  
5.1.1 BioWin 3.1® Integrated Model  
 
The BioWin 3.1® Integrated Model is a biochemical mass balance model that characterizes organic 
wastewater components in terms of COD.  The model describes biological processes, chemical 
precipitation reactions and gas-liquid mass transfers using fifty state variables and sixty process 
expressions.   Because it incorporates many different process units, the model is well suited for 
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simulating entire WWTPs.  This work focused on the processes within the overall model that address 
the behavior of heterotrophic biomass in aerobic systems and the associated consumption of 
substrates and generation of byproducts.  The selection of the appropriate parameter values for these 
processes was an important element of the model implementation. 
 





C (Henze et al., 2008).  A value of 0.6 was assumed for Yh since this was the value 
reported by Ramdani et al. (2012) for acetate-fed systems.  These values are based on the endogenous 
respiration approach to describe the kinetics of cell maintenance, endogenous metabolism, decay, 
lysis and death.  However, the BioWin 3.1® Integrated Model employs the death-regeneration 









C using equation 4.12.  The f value is 
considered to be independent of temperature.   
 
Besides μa, bh, Yh and f, the default values in the BioWin® 3.1 Integrated Model were used for the 
other kinetic and stoichiometric parameters.  As mentioned, the model was used to simulate the Phase 





C, respectively, and then the model was calibrated by systematically adjusting Yh, f and bh within 
their respective typical ranges.  This will be described in section 5.2. 
 
 
5.1.2 ASM3 Model  
 
The ASM3 Model simulates oxygen consumption, sludge production, nitrification and denitrification 
in activated sludge systems treating wastewater of primarily domestic origin.  Compared to the 
BioWin 3.1® Integrated Model, the ASM3 Model is much simpler as it has only thirteen state 
variables and twelve reactions.  The ASM3 Model is designed to be the core of many different 
models.  Although it does not include modules for biological phosphorus removal, chemical 
precipitation, growth of filamentous organisms or pH calculations, they can easily be connected as 
add-on modules (Henze et al., 2000).   
 
The matrix representation of the ASM3 Model in the BioWin platform is presented in Table 5.1.  This 
matrix shows only the processes that were believed to be involved in the Phase 1 BR-AD system.  
Therefore, anoxic processes and the growth and endogenous respiration of autotrophs were omitted 
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because these processes were determined to be negligible.  The BR and AD were always operated 
aerobically and the measured nitrate levels in the various sludge streams were consistently below 1 
mg N/L.  Both the stoichiometric matrix and kinetic rate expressions shown in Table 5.1 were 
adapted to the BioWin® platform from the ASM3 Model proposed by Henze et al. (2000).  The 
matrix employs symbols specific to the BioWin® platform for compounds and kinetic and 
stoichiometric parameters.  The ASM3 Model does not include a variable for acetate (Sbsa) thus all 
rbCOD was represented as Sbsc.  Furthermore, the ASM3 Model does not include a variable for slowly 
biodegradable colloidal COD (Xsc) thus all slowly biodegradable COD was represented as Xsp.  The 
ASM3 Model does not differentiate endogenous residue from other non-biodegradable particulate 
COD and therefore represented both as Xi.  Stored COD in the ASM3 Model is represented by the 
symbol Sphb in the BioWin® platform.  Therefore, Sphb will be used to denote stored COD in this 
chapter.  The ASM3 Model matrix presented by Henze et al. (2000) included independent variables 
for alkalinity and suspended solids however each of these variables is a combined variable in the 
BioWin® platform.  Therefore, these variables were calculated according to the BioWin method 





Table 5.1 ASM3 Model in BioWin® Platform Showing Processes in Phase 1 BR-AD System 
Process 
 
DO Sbsc NH3-N Xi Xsp Zbh Sphb 





mg N/L mg COD/L 
Hydrolysis  1 
 
 -1   
 
Aerobic storage 
of Sbsc by Zbh  
-1      
 
Aerobic growth of 
Zbh on Sphb  




respiration of Zbh 
  
 
  -1   
Aerobic 
respiration of Sphb 
-1      -1  
 
The values of the kinetic and stoichiometric parameters that were described in Table 5.1 are presented 
in Table 5.2.  These values were determined by Koch et al. (2000) for the calibrated ASM3 Model at 
20
o
C.  The values of temperature-dependent kinetic parameters were calculated at 25
o
C using the 
corresponding coefficient θT reported by Koch et al. (2000) and the ASM3 temperature equation 
presented by Henze et al. (2000).  When the ASM3 Model was run in the BioWin® platform, the 
COD/VSS ratio of storage products was specified as 1.1 gCOD/gVSS because this is the typical value 
for glycogen which was believed to be stored inside the cells.  The particulate inert COD/VSS ratio 
was specified as 1.42 gCOD/gVSS because the inert fraction was expected to be solely comprised of 





Table 5.2 Kinetic and Stoichiometric Parameters in ASM3 Model for Phase 1 BR-AD System 









Hydrolysis rate constant   9 11 
Hydrolysis saturation constant   1 
Aerobic storage rate constant   12 17 
Inhibition constant for oxygen (DO)   0.2 
Saturation constant for substrate (Sbsc)   10 
Saturation constant for storage   0.1 
Heterotrophic maximum aerobic growth rate   3 4.3 
Saturation constant for ammonia (NH3-N)   0.1 
Aerobic endogenous respiration rate of Zbh   0.3 0.4 
Production of Xi in endogenous biomass respiration   0.2 
Aerobic yield of stored products per Sbsc   0.80 
Aerobic yield of heterotrophic biomass growth on Sphb   0.80 
Nitrogen content of Sbsc   0.03 
Nitrogen content of Xi   0.04 
Nitrogen content of Xsp   0.03 
Nitrogen content of Zbh   0.07 
 
The ASM3 Model with the values presented in Table 5.2 was used in the BioWin® platform to 
simulate the Phase 1 BR-AD system.  The predicted responses were then matched to the measured 




5.2 Phase 1 System Modeling 
 
The BioWin 3.1® Integrated Model and the ASM3 Model were each used to simulate the Phase 1 
BR-AD system.  A trial and error approach was used to initially estimate the values of the key kinetic 
and stoichiometric parameters such that the predicted concentrations of particulate COD species in 
the BR and AD WAS were statistically equivalent to the corresponding average measured 
concentrations using t-tests at the 95% confidence level.  Following this, a least squares regression 
between the predicted and measured OUR responses from offline respirometry on BR WAS was 
employed to improve the accuracy of the estimates of the parameter values.  
    
Using a trial and error approach, the value of Yh was adjusted while f and bh were held constant at 
their initially assumed values, i.e. 0.09 and 0.53 d
-1
, respectively.  For each new value of Yh, the 
system was simulated using the BioWin 3.1® Integrated Model.  The values of Yh that yielded 
simulated particulate COD concentrations in the reactors that were statistically equivalent to 
respective measured concentrations were recorded.  Using these Yh values, the offline respirometric 
test on BR WAS was then simulated.  The Yh value that minimized the sum of squared differences 
between predicted and measured OUR responses was thus determined.  This approach was repeated a 
second time by adjusting f while keeping bh and Yh constant at 0.53 d
-1
 and 0.6, respectively.  This 
approach was repeated a third time by adjusting bh while keeping f and Yh constant at 0.09 and 0.6, 
respectively.  It was found that the model best fit the measured data when the values of Yh, f and bh 




C, respectively.  Thus the calibrated model employed the initially 
assumed values of f and bh whereas the Yh value was changed from the initially assumed value of 0.6 
that was developed from systems fed by acetate.  This Yh of 0.67 was believed to be reasonable as it 
is the standard value reported by Henze et al. (2008) for ordinary heterotrophic organisms. 
     
The same trial and error approach described above for the BioWin Model was used to calibrate the 
ASM3 Model except that the adjusted parameters were bH,O2 and μh.  The initially assumed values of 
bH,O2 and μh were 0.3 d
-1
 and 3 d
-1
, respectively.  It was found that the best fit was achieved using bH,O2 
and μh values of 0.3 d
-1




C, respectively.  Thus the calibrated model employed the 
initially assumed value of bH,O2.  However, the calibrated model employed a μh value that was much 
lower than the initially assumed value of 3 d
-1
, i.e. the value reported by Koch et al. (2000).  This 
indicated that the heterotrophic growth rate was lower in the current study.  This difference may have 
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been because the current study employed synthetic wastewater whereas Koch et al. (2000) used 
municipal wastewater.   
 
Tables 5.3 and 5.4 present the measured concentrations of COD, SS and nitrogen species in the Phase 
1 BR-AD system and the corresponding values predicted by the calibrated BioWin 3.1® Integrated 
Model and the calibrated ASM3 Model.  Percent differences between corresponding simulated and 
measured values are shown and significant differences, as defined by t-test hypotheses at the 95% 
confidence level, are shaded grey.  
      
Table 5.3 Measured and Simulated COD, SS and N Species in BR WAS 
Parameter 










PCOD 4127 334 4315 5 4218 2 
SCOD 52 14 53 2 53 2 
ffCOD 53 12 53 0 53 0 
VSS 3342 167 3039 9 3374 1 
ISS 489 103 320 35 358 27 
NO3-N 0.1 0.1 0 100 0 100 
NH3-N 73 11 71 3 70 4 
Concentrations in mg/L 
 
Table 5.4 Measured and Simulated COD, SS and N Species in Phase 1 AD WAS 
Parameter 










PCOD 2119 218 2208 4 2142 1 
SCOD 309 30 53 83 53 83 
ffCOD 190 11 53 72 53 72 
VSS 1667 117 1577 5 1648 1 
ISS 980 85 745 24 732 25 
NO3-N 0.3 0.4 0 100 0 100 
NH3-N 112 9 108 4 113 1 
Concentrations in mg/L 
 
As shown in Tables 5.3 and 5.4, both models were successfully calibrated in terms of predicting 
PCOD concentrations in the BR and AD WAS that were statistically equivalent to the respective 
average measured concentrations.  As expected, the predicted SCOD and ffCOD concentrations in the 
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BR and AD WAS were equivalent to the Sus concentration in the synthetic feed, i.e. 53 mg/L, because 
neither model addresses the generation of Sus.   
 
The predicted NH3-N concentrations in the WAS from the BR and AD processes were statistically 
equivalent to the respective average measured concentrations.  This finding validated the model 
calibration as the NH3-N response was independent of the calibration.  The predicted nitrate (NO3-N) 
concentrations significantly differed from measured levels.  However, both predicted and measured 
concentrations were very close to zero and therefore considered negligible.   
 
Neither model accurately predicted the ISS concentration in the BR or AD WAS.  This was expected 
because the processes involving ISS were not well developed in either model.  The predicted ISS 
response was not expected to significantly impact the behaviour of particulate COD throughout the 
system.   
 
Compared to the measured VSS concentrations, the BioWin 3.1® Integrated Model predicted a 9% 
lower concentration in the BR WAS and a 5% lower concentration in the AD WAS.   Both these 
differences were significant however the 5% difference was considered minimal.  The 9% difference 
may have been due to the fact that the model employed the typical COD/VSS ratio of 1.42 whereas 
the average measured COD/VSS ratio of the BR WAS was 1.23 ± 0.08.  Compared to the measured 
VSS concentrations, the ASM3 Model predicted a 1% higher concentration in the BR WAS and a 1% 
lower concentration in the AD WAS however both these differences were insignificant.  This finding 
validated the ASM3 Model calibration as the VSS response was independent of the calibration.  
         
In addition to the PCOD concentrations, the calibration of the models was based on predicting Zbh, Ze 
and Sphb concentrations in the BR and AD WAS that were statistically equivalent to the corresponding 
average measured concentrations.  Tables 5.5 and 5.6 present the concentrations of Zbh, Ze and Sphb in 
the Phase 1 BR-AD system estimated using the calibrated models.  Percent differences between 
corresponding simulated and measured values are shown and significant differences, as defined by t-
test hypotheses at the 95% confidence level, are shaded grey.  




Table 5.5 Measured and Simulated Zbh, Ze and Sphb in BR WAS  
Para-
meter 




















PCOD 4127 334   4315  5 4218  2 
Zbh 2133 73 52 5 3452 80 62 2109 50 1 
Ze 512 17 12 1 863 20 69 548 13 7 
Sphb 1543 205 37 6 0 0 100 1561 37 1 
Concentrations in mg/L 
 
Table 5.6 Measured and Simulated Zbh, Ze and Sphb in Phase 1 AD WAS  
Para-
meter 




















PCOD 2119 218   2208  4 2142  5 
Zbh 1200 260 57 11 1281 58 7 1116 52 7 
Ze 1090 350 51 17 927 42 15 982 46 10 
Sphb 0 0 0 0 0 0 0 44 2 100 
Concentrations in mg/L 
 
The BioWin model could not be calibrated to predict Zbh, Ze and Sphb concentrations in the BR WAS 
that were statistically equivalent to the respective average measured concentrations while also 
satisfying the condition that the predicted PCOD concentrations in the BR and AD WAS be 
statistically equivalent to the respective average measured concentrations.  The offline respirometric 
measurements indicated that a portion of the synthetic feed remained stored inside the BR biomass.  
The presence of stored COD resulted in less grown biomass and hence less decay of biomass to 
produce Ze.  However, the BioWin model assumed that the COD of the synthetic feed was completely 
oxidized by the BR biomass with the SRT employed.  Therefore, the model overestimated the Zbh and 
Ze concentrations in the BR WAS when compared to the respective measured concentrations.  The 
BioWin model was successfully calibrated in terms of predicting Zbh, Ze and Sphb concentrations in the 
AD WAS that were statistically equivalent to the corresponding measured concentrations and this was 
because the measured Sphb concentration in the AD WAS was negligible.   
 
The ASM3 Model was successfully calibrated in terms of predicting Zbh and Sphb concentrations in the 
BR WAS that were statistically equivalent to the respective measured concentrations.  This model 
therefore successfully accounted for the presence of stored COD in the BR WAS.  The Ze 
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concentration in the BR WAS predicted by this model was significantly higher than the measured 
concentration although the difference was 7% which was considered to be relatively small.  The 
ASM3 Model was also successfully calibrated in terms of predicting Zbh and Ze concentrations in the 
Phase 1 AD WAS that were statistically equivalent to the respective measured concentrations.  The 
calibrated ASM3 Model predicted that 44 mg/L of Sphb remained in the AD WAS whereas the 
measurements indicated that Sphb was fully depleted in the AD.  However, this predicted Sphb 
concentration was only 2% of the PCOD and hence was considered negligible. 
 
Overall, the Zbh, Sphb and Ze concentrations in the BR and AD WAS predicted by the calibrated ASM3 
Model were deemed to be comparable to those estimated from the offline respirometric measurements 
despite the fact that the modeling and respirometric approaches employed different values of Yh, bh 







C, respectively.  The net yield of heterotrophic biomass (Yh) was the product of 
YSTO,O2 and YH,O2, i.e. 0.64.  By comparison, equations 2.3 and 4.15 used to estimate Zbh and Ze from 
respirometry employed Yh, bh and muh values of 0.6, 0.24 d
-1




In addition to predicting particulate COD concentrations in the reactors that were statistically 
equivalent to the respective measured concentrations, the calibration of the models was also based on 
minimizing the sum of squared differences between the measured and predicted OUR responses from 
offline respirometry on the BR WAS.  Figure 5.2 shows the OUR responses in the BR WAS 
measured by offline respirometry and simulated by the calibrated models.  The measured OUR curve 
in Figure 5.2 was typical of that obtained throughout Phases 1 and 2.   
 




From Figure 5.2 it can be seen that the measured OUR curve initially declined, peaked and then 
decreased exponentially which suggested that biomass growth, COD oxidation and endogenous 
respiration occurred during the test.  The calibrated BioWin Model successfully predicted only the 
endogenous response, i.e. from 55 hours onwards.  It was not possible to adjust the kinetic or 
stoichiometric parameters in the BioWin Model to simulate the growth or COD oxidation observed in 
the batch test because this model did not include processes for COD storage by Zbh.  The BioWin 
Model was therefore deficient in this regard.  Although the OUR curve predicted by the calibrated 
ASM3 Model did not demonstrate a peak, it did plateau and then decrease exponentially which 
suggested that COD oxidation and endogenous respiration occurred during the test.   These results 
and the predicted and measured Zbh, Ze and Sphb concentrations in the BR WAS, previously presented 
in Table 5.5, indicate that the calibrated ASM3 Model was better suited to simulate the BR-AD 
system than the calibrated BioWin Model.  Therefore, the calibrated ASM3 Model was selected to 
subsequently simulate the Phase 1 and 2 systems. 
 
Using the calibrated ASM3 Model, the measured and simulated OUR responses in the batch 
respirometric tests of inoculated BR WAS and AD WAS were subsequently compared, as shown in 
Figure 5.3.  The model successfully predicted the OUR response due to oxidation of stored COD and 
endogenous respiration in the inoculated BR WAS.  The model also correctly predicted the 
endogenous OUR response in the AD WAS.  The apparent success of these two predicted responses 
was considered to validate the calibration of the ASM3 Model since these responses were 
independent from the calibration.       
 





The OUR response in the AD simulated by the calibrated ASM3 Model was compared to the OUR 
response measured by online respirometry during Phase 1, as shown in Figure 5.4.  As mentioned in 
section 4.3.1, there was only one viable online respirometric test in Phase 1.  
 
 
Figure 5.4 Measured and Simulated OUR from Online Respirometry in Phase 1 AD 
 
Similar to the measured OUR curve in each reaction period, the simulated curves in Figure 5.4 
appeared to be decay-dominated.  The areas under the predicted and measured OUR curves in each 
reaction period were comparable which indicated that the predicted and measured total oxygen uptake 
in each reaction period were comparable.  However, the simulated OUR curve somewhat 
underestimated the OUR immediately after feeding and somewhat overestimated the OUR over the 
second half of the reaction period.  As shown in Figure 5.4, the observed OUR in the Phase 1 AD 
immediately after feeding was 10.5 mgO2/L/h, and this decreased over the reaction period to 5.5 
mgO2/L/h.  By comparison, the OUR in the AD predicted by the calibrated ASM3 Model was 8.9 
mgO2/L/h immediately feeding, and this decreased over the reaction period to 6.4 mgO2/L/h.  Since 
there was only one viable measured response, additional experiments should be carried out to further 
assess the extent to which the OUR response predicted by the calibrated ASM3 Model may deviate 






5.3 Phase 2 System Modeling 
 
The calibrated ASM3 Model that was used to simulate the Phase 1 system was subsequently 
employed to simulate the Phase 2 system with the same kinetic and stoichiometric parameter values.  
Once the simulated Phase 1 system was at steady state, the feed to the AD was switched from BR 
WAS to an influent intended to represent the pretreated BR WAS, labeled “PT” in Figure 5.5.  The 
simulation was continued for a number of days until a new steady state condition was reached.  The 
configuration of this switchover from Phase 1 to 2 in the BioWin 3.1® platform is shown in Figure 
5.5.     
 
Figure 5.5 Configuration of Switchover from Phase 1 to 2 in BioWin® 3.1 Platform 
 
As discussed in section 5.2, the predicted steady-state concentrations of the COD species in the BR 
WAS were found to be statistically equivalent to the respective average measured concentrations 
except for Ze which was 7% higher than the measured concentration.  However, this 7% difference 
was considered relatively small hence the predicted composition of the BR WAS was deemed 
representative of the measured composition.  The simulated BR WAS contained 53 mg/L Sus, 2109 
mg/L Zbh, 548 mg/L Ze and 1561 mg/L Sphb.  Thus the simulated TCOD concentration was 4271 
mg/L.  
  
The simulated composition of the BR WAS was used to estimate several properties of the pretreated 
BR WAS, as follows:   
 The simulated pretreated BR WAS was assigned the same concentrations of ISS, phosphate, 
magnesium, calcium, alkalinity, cations and anions as were in the simulated BR WAS.   
 The TCOD concentration in the pretreated BR WAS was assumed to be equivalent to that in 
the BR WAS because it was demonstrated in section 4.2.3 that TCOD was conserved during 
pretreatment.   
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 The Sus concentration in the simulated pretreated BR WAS was assumed to be equivalent to 
that in the BR WAS because it was shown in section 4.2.4 that pretreatment did not generate 
this type of COD.   
 The Xi concentration in the pretreated BR WAS was assumed to be equivalent to that in the 
BR WAS, i.e. the concentration of endogenous residue in the BR WAS, because it was shown 
in section 4.2.4 that pretreatment did not alter the biodegradable fraction of the WAS.   
 The Sphb concentration in the BR WAS was assumed to be fully converted to Sbsc by 
pretreatment because it was assumed that the storage products in the BR WAS were released 
upon cell inactivation by pretreatment.   
 The Zbh in the BR WAS was assumed to be converted to a mixture of Sbsc and Xsp by 
pretreatment.   
Therefore, the simulated pretreated BR WAS contained 53 mg/L Sus, 548 mg/L Ze and the remaining 
3670 mg COD/L was assumed to be bCOD comprised of a mixture of Sbsc and Xsp.  Thus the bCOD 
comprised 86% of the TCOD of the pretreated BR WAS. 
 
The measured concentrations of nitrogen species presented in chapter 4 were used to estimate the 
nitrogen species in the simulated pretreated WAS.  As shown in section 4.2.3, pretreatment 
solubilized organic nitrogen but did not change the ammonia concentration in the WAS.  Therefore 
the same ammonia concentration predicted in the BR WAS was assumed to be present in the 
pretreated BR WAS, i.e. 70 mg N/L.  The particulate organic nitrogen (Xon) concentration in the 
pretreated BR WAS was assumed to be the product of the typical nitrogen content of biomass (0.07 
mg N/mg COD) and the sum of Xsp and Xi since Xsp originated from biomass and Xi was comprised 
of endogenous residue.  Similarly, the soluble organic nitrogen (Nos) concentration in the pretreated 
BR WAS was assumed to be the product of the typical nitrogen content of biomass (0.07 mg N/mg 
COD) and the Sbsc concentration in the pretreated BR WAS that originated from Zbh in the BR WAS.  
The Sbsc in the pretreated BR WAS that originated from Sphb in the BR WAS was assumed to be 
absent of nitrogen since glycogen, the likely storage product, does not contain nitrogen.  
  
The Phase 2 system was simulated as described above for various concentrations of Sbsc and Xsp in the 
pretreated BR WAS while maintaining a bCOD concentration of 3670 mg/L and a minimum Sbsc 
concentration of 1561 mg/L, i.e. the concentration of Sbsc originating from Sphb in the BR WAS.  A 
trial and error approach was used to initially estimate the Sbsc and Xsp concentrations such that the 
predicted concentrations of PCOD and SCOD in the pretreated BR WAS and PCOD in the Phase 2 
AD WAS were statistically equivalent to the respective measured concentrations using t-tests at the 
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95% confidence level.  Following this, a least squares regression between the predicted and measured 
OUR responses from offline respirometry on the inoculated pretreated BR WAS was employed to 
improve the accuracy of the Sbsc and Xsp estimates.  Based on this approach the concentrations of Sbsc 
and Xsp in the pretreated BR WAS were estimated to be 2316 mg/L and 1354 mg/L.  Table 5.7 
presents the simulated and measured PCOD and SCOD concentrations in the pretreated BR WAS.  
   
Table 5.7 Measured and Simulated COD Species in Pretreated BR WAS  
Parameter 
Measured ASM3 Model 
Avg. Std. dev. Parameter Predicted Difference from Measured (%) 




SCOD 2369 228 
Sbsc 2316 2369 0 
Sus 53 
Concentrations in mg/L 
 
In Table 5.7 the predicted PCOD concentration was the sum of the predicted Xsp and Ze 
concentrations.  Although the predicted PCOD concentration was 7% higher than the average 
measured concentration, this difference was insignificant at the 95% confidence level.  The predicted 
SCOD concentration, which was the sum of the predicted Sbsc and Sus concentrations, was identical to 
the average measured SCOD concentration.   
 
Employing Sbsc and Xsp estimates of 2316 mg/L and 1354 mg/L, respectively, in the pretreated BR 
WAS also resulted in the predicted PCOD concentration in the Phase 2 AD WAS being statistically 
equivalent to the average measured concentration.  The predicted and measured PCOD concentrations 
in the Phase 2 AD WAS are shown in Table 5.8.  In addition, Table 5.8 compares the predicted and 
measured SCOD, ffCOD, VSS, ISS, NO3-N and NH3-N concentrations.  Percent differences between 
corresponding simulated and measured values were calculated and significant differences, determined 





Table 5.8 Measured and Simulated COD, SS and N Species in Phase 2 AD WAS  
Parameter Measured ASM3 Model 
Avg. Std. dev. Predicted Difference from Measured 
(%) 
PCOD 1861 67 1898 2 
SCOD 237 31 53 78 
ffCOD 177 31 53 70 
VSS 1557 90 1518 3 
ISS 528 44 732 39 
NO3-N 0.9 0.9 0 100 
NH3-N 112 9 113 1 
Concentrations in mg/L 
As shown in Table 5.8, the model predicted VSS and NH3-N concentrations in the Phase 2 AD that 
were statistically equivalent to the respective measured concentrations. It is believed that this finding 
validated the estimation of the Sbsc and Xsp concentrations in the pretreated BR WAS since the VSS 
and NH3-N responses were independent of the calibration responses.  The predicted NO3-N 
concentration significantly differed from the measured values however both the predicted and 
measured concentrations were very close to zero and therefore considered negligible.  As expected, 
the model did not predict the generation of Sus in the AD hence the simulated SCOD and ffCOD 
concentrations were significantly lower than measured.  Also as expected, the model did not 
accurately predict the concentration of ISS in the AD.   
 
Table 5.9 compares the steady-state concentrations of Zbh, Ze and Sphb in the Phase 2 AD WAS 
estimated from offline respirometric measurements to the respective simulated concentrations.  The 
simulated concentrations were determined using the calibrated ASM3 Model with Sbsc and Xsp 
estimates of 2316 mg/L and 1354 mg/L, respectively, in the pretreated BR WAS.  Percent differences 
between corresponding simulated and measured values were calculated.  T-test hypotheses at the 95% 
confidence level were used to determine significant differences and these are shaded grey in Table 





Table 5.9 Measured and Simulated Zbh, Ze and Sphb in Phase 2 AD WAS  
Parameter 
Measured ASM3 Model 
Avg. Std. dev. % of PCOD 
Avg. % of PCOD 
Difference from 
Measured (%)    Avg. Std. dev. 
PCOD 1861 67   1898  2 
Zbh 700 150 38 8 833 44 19 
Ze 850 270 46 15 1017 54 20 
Sphb 0 0 0 0 48 2 100 
Concentrations in mg/L 
 
The model predicted that 2% of the PCOD of the Phase 2 AD WAS consisted of Sphb whereas the 
batch respirometric measurements indicated that Sphb was absent.  However, this predicted level was 
relatively small when compared to the uncertainty associated with the test method and therefore 
considered negligible.  The predicted concentrations of Zbh and Ze were significantly different from 
the respective measured concentrations.  As mentioned in section 4.3.2.4, the sum of the measured 
COD fractions in the Phase 2 AD WAS was significantly less than the measured TCOD of the WAS, 
resulting in a significant COD closure error.  This indicated that there were inaccuracies in the 
estimates of Zbh and Ze in the Phase 2 AD WAS based on the batch respirometric measurements.  The 
predicted Zbh and Ze concentrations were believed to be more accurate because the predicted PCOD 
and VSS concentrations were statistically equivalent to the respective average measured levels.  
Although the Zbh concentration in the Phase 2 AD WAS predicted by the calibrated ASM3 Model was 
19% higher than the measured concentration, it was still significantly less than either the measured or 
predicted Zbh concentration in the Phase 1 AD WAS.  This finding was consistent with the observed 
OUR responses in batch respirometry bottles containing AD WAS.  
    
In addition to matching predicted and measured COD concentrations in the pretreated  BR WAS and 
Phase 2 AD WAS, the estimation of the Sbsc and Xsp concentrations in the pretreated BR WAS was 
also based on minimizing the sum of squared differences between the predicted and measured OUR 
responses from offline respirometry on inoculated pretreated BR WAS.  These predicted and 




Figure 5.6 Measured and Simulated OUR from Offline Respirometry on Inoculated Pretreated BR WAS  
 
As mentioned in section 4.3.2.2, seven valid offline respirometric measurements were carried out 
during Phase 2 and an analysis of the results showed four of the tests were conducted with AD 
biomass that was acclimatized to the pretreated BR WAS.   The OUR responses measured during 
these tests (days 243, 250, 264 and 271) are shown in Figure 5.6.  Although there was considerable 
variability among the four measured responses, each curve showed growth, substrate oxidation and 
endogenous respiration.  Each measured curve showed a sharp peak within the first 20 hours of the 
test, suggesting growth on Sbsc.  Following this, substrate oxidation appeared to dominate the four 
measured OUR responses until approximately 60 hours.  In the tests started on days 250, 264 and 
271, the endogenous response became visible after approximately 60 hours.  The measured OUR 
response from the sample taken on day 243 showed a peak between 60 and 70 hours, suggesting 
delayed biomass growth.  However, the area under this peak comprised only 5% of the total area 
under the curve.  Therefore, this delayed peak was considered negligible.  
  
A variable volume reactor labeled “OUR Test” was included in the configuration in Figure 5.5 to 
simulate the offline batch respirometric tests with BR WAS pretreatment.  Once the Phase 2 system 
was at steady-state, 150 mL of pretreated BR WAS and 50 mL of AD WAS was fed to the OUR Test 
reactor and the simulation was continued for a number of days.   
 
In the initial round of calibrations it was found that when the Sbsc to Xsp ratio in the pretreated BR 
WAS ranged from 1.6 to 1.8 and the bCOD concentration of the pretreated BR WAS was equal to 
3670 mg/L, the predicted PCOD and SCOD concentrations in the pretreated BR WAS and predicted 
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PCOD concentration in the AD WAS were statistically equivalent to the corresponding measured 
concentrations.  Hence, in the refined calibration, the OUR Test reactor was simulated five times 
using Sbsc to Xsp ratios of 1.60, 1.65, 1.70, 1.75 and 1.80.   The sum of squared differences was 
calculated between each of the four measured OUR responses and each of the five simulated OUR 
responses.  For each of the four measured responses, the simulated response that yielded the 
minimum sum of squared differences was determined.  It was found that the best fit estimates of Sbsc 
to Xsp ratios varied over the full extent of the tested range, i.e. 1.6 to 1.8.  Therefore, the accuracy of 
the estimated Sbsc and Xsp concentrations could not be further improved using this least squares 
regression approach.  The median value of the Sbsc to Xsp ratio (1.7) was selected and the simulated 
OUR response associated with this ratio is shown in Figure 5.6.  The Sbsc to Xsp ratio of 1.7 
corresponded to the previously mentioned estimated Sbsc and Xsp concentrations of 2316 mg/L and 
1354 mg/L, respectively.  The simulated OUR response appeared to be comprised of two overlapping 
peaks.  An analysis of the modeling results showed that the higher and sharper peak was associated 
with biomass growth on Sbsc whereas the lower and more gradual peak was associated with biomass 
growth on Xsp.       
  
The OUR response in the Phase 2 AD was simulated by the calibrated ASM3 Model with pretreated 
BR WAS containing Sbsc and Xsp concentrations of 2316 mg/L and 1354 mg/L.  The simulated 
response was compared to the OUR response measured by online respirometry, as shown in Figure 
5.7.  The measured response in Figure 5.7 was typical of the OUR responses measured by online 
respirometry throughout Phase 2.     
 




As shown in Figure 5.7, the measured OUR in the Phase 2 AD appeared to be decay-dominated as it 
decreased relatively slowly from 10.5 mgO2/L/h immediately after feeding to 5.5 mgO2/L/h at the end 
of the reaction period.  By comparison, the simulated OUR in the AD spiked to 42 mgO2/L/h 
immediately after feeding, decreased to 13.5 mgO2/L/h within approximately 45 minutes, decreased 
to 9 mgO2/L/h within approximately 3 hours, and then gradually decreased over the reaction period to 
approximately 5.5 mgO2/L/h.  Although the simulated curve appeared to fit the measured curve from 
approximately 4 hours after feeding until the end of the reaction period, the simulated curve showed a 
relatively high spike immediately after feeding that was not observed in the measured response.  As 
explained in section 4.3.2.2, it was hypothesized that the online respirometric measurements failed to 
capture rapid and high oxygen uptake.  Typically 1 hour was required to increase the DO 
concentration from 3 to 5 ppm immediately after the AD was fed with pretreated BR WAS.  For the 
remainder of the reaction period, the DO concentration was typically increased from 3 to 5 ppm 
within 5 minutes.  This delay was presumably due to insufficient aeration in the AD.  An analysis of 
the simulated OUR response showed that the spike immediately after feeding was due to the aerobic 
growth on Sbsc.  Apart from this, both the simulated and measured OUR curves appeared to show the 
oxidation of Xsp, followed by endogenous respiration.  
 
 
5.4 Pretreatment Model 
 
This section describes the approach taken to develop the pretreatment model.  The COD fractionation 
of the WAS before and after pretreatment predicted by the calibrated Phase 2 ASM3 Model was 
summarized in Table 5.10.  The data in Table 5.10 was used to develop a COD-based stoichiometric 
pretreatment model that is compatible with the Petersen matrix-based models employed in most 
wastewater treatment simulators, as shown in Table 5.11.  Based on the data in Table 5.10, 36% of 
Zbh in the BR WAS was converted to Sbsc and the remainder was converted to Xsp.  Thus the fraction 
of Zbh converted to Sbsc (fSbscZbh) in Table 5.11 was 0.36.  As existing simulators do not have the 
functionality to accommodate instantaneous transformation processes, kinetic processes were 
employed and the rate constants, kd_Zbh and kd_Sphb, were assigned very high values, i.e. 1000 d
-1
, so 
that the rates were effectively instantaneous.  In accordance with the experimental results, the 
pretreatment model conserved TCOD and did not generate ammonia.    















Sphb  1561 37 Sbsc (from Sphb) 1561 36 
Zbh  2109 49 
Sbsc (from Zbh) 755 18 
Xsp 1354 32 
Ze 548 13 Ze 548 13 
Sus 53 1 Sus 53 1 
TCOD 4271 100 TCOD 4271 100 
   
Table 5.11 Pretreatment Model 
Process 
Sbsc Xsp Zbh Sphb Kinetic Rate 
Expressions mg COD/L 
Conversion of Heterotrophs   -1   
Release of Stored COD 1   -1  
 
To verify the model, a reactor was added directly upstream of the aerobic digester in the configuration 
presented in Figure 5.1.  This reactor was specified as a BioWin model builder unit with the 
pretreatment model presented in Table 5.11 to simulate the pretreatment dose employed in this study.  
The overall system was simulated with the calibrated ASM3 Model that was fit in Phase 1 and the 
simulations were continued until the AD reached steady state.  The configuration of this Phase 2 
system is presented in Figure 5.8.      
     
Figure 5.8 Configuration of Phase 2 System in BioWin® 3.1 Platform 
 
The steady-state concentrations of COD, SS, ammonia and nitrate in the Phase 2 AD using the system 
configuration in Figure 5.8 were identical to the respective concentrations in the Phase 2 AD using 
the configuration presented previously in Figure 5.5.  Likewise, the OUR responses in the online and 
offline tests simulated using the configuration in Figure 5.8 were identical to those simulated using 
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the configuration in Figure 5.5.  It was therefore concluded that the pretreatment model presented in 
Table 5.11 accurately described the COD transformations associated with the HPTH pretreatment 
dose employed in this study.   
 
The COD-based stoichiometric pretreatment model proposed in Table 5.11 was somewhat specific to 
the system in this study.  The model was based on using the ASM3 Model in the BioWin platform for 
a non-nitrifying aerobic system treating WAS comprised of Zbh, Ze and Sphb.  However, the approach 
described in this study may be followed to determine the impacts of pretreatment on Zbh, Ze and Sphb 
when other doses of HPTH pretreatment and other pretreatment techniques are employed.  It would 
seem to be reasonable to assume that other types of biomass typically occurring in WWTPs would be 
undergo similar conversions through pretreatment as was observed for Zbh in this study.  However, 
tests should be carried out to verify this.  The proposed pretreatment model did not generate ammonia 
which was in accordance with the experimental results.  The model did not account for the possible 
impacts of pretreatment on phosphorous species since the measurement of these species was outside 







This study sought to characterize and develop a COD based model for WAS pretreatment by HPTH 
and it is believed that all of the objectives were met.  The COD of a raw and pretreated synthetically 
generated WAS was fractionated using analytical and bioassay methods and activated sludge 
modeling.  It was found that HPTH WAS pretreatment at 150
o
C and 3 bars for 30 minutes increased 
the rate at which the WAS was aerobically biodegraded but did not increase the extent of 
biodegradation.  A COD-based pretreatment model was then developed and the applicability of the 
model was assessed.  The following summarizes the specific conclusions that were made. 
 
In the study it was found that stored COD was present in the synthetically generated (BR) WAS.  This 
conclusion was based on the following independent results:   
 The average measured COD/VSS ratio of the BR WAS was 1.23 ± 0.08 which was 
significantly lower than the typical value of 1.42 for active biomass and decay products.  This 
suggested that stored COD such as glycogen was present since it has a relatively low 
COD/VSS ratio of 1.1.   
 The average measured pON/PCOD ratio of the BR WAS was 0.053 ± 0.006 mg N/mg COD 
which was significantly lower than the typical value of 0.07 mg N/mg COD for active 
biomass and decay products.  Because typical storage products such as glycogen or PHA do 
not contain nitrogen, this lower measured ratio suggested that storage products were present.   
 The average measured ffCOD concentration in the AD WAS was significantly higher than 
that in the BR WAS which suggested that Sus was generated in the AD.  Prior research has 
shown that the decay of cells storing COD generated Sus.  Therefore, the production of Sus in 
the AD supported the hypothesis that storage products were present in the biomass fed to the 
AD.   
 The OUR responses from offline respirometry on BR WAS showed both growth and decay.  
It appeared that stored COD was consumed during the batch respirometry and exerted an 
oxygen demand that was greater than that which would have been attributed to endogenous 
respiration.        
 The BR WAS was estimated to contain 51 ± 4% Zbh and 12 ± 1% Ze based on an analysis of 
the data from the offline respirometric test on mixtures of BR WAS and synthetic feed in 
high F/M ratios.  The calibrated ASM3 Model employed to simulate the Phase 1 BR-AD 
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system verified these Zbh and Ze COD fractions in the BR WAS and predicted that the 
remaining 37% was essentially comprised of XSTO.   
 
It was concluded that stored COD was not present in the AD WAS.  This conclusion was based on 
two findings: the average measured COD/VSS ratio in the AD WAS was statistically equivalent to 
the typical ratio for Zbh and Ze; and the OUR curves from offline respirometry on AD WAS showed 
only decay and no growth.  Therefore, the stored COD present in the BR WAS was depleted in the 
AD.   
 
This study showed that HPTH pretreatment at 150
o
C and 3 bars for 30 minutes did not reduce the 
TCOD concentration of the WAS.  This conclusion was based on the finding that the average TCOD 
concentrations of the raw and pretreated BR WAS were statistically equivalent.   
 
The dose of pretreatment employed in this project did not mineralize organic nitrogen as the average 
ammonia concentration in the BR WAS did not significantly increase after pretreatment.   
 
HPTH pretreatment at 150
o
C and 3 bars for 30 minutes solubilized 56 ± 7% of COD, 49% ± 11% of 
organic nitrogen, 56 ± 10% of VSS and did not solubilize ISS.  All types of particulate organics were 
solubilized to the same extent by pretreatment as the average measured pON/PCOD ratio of the BR 
WAS was statistically equivalent to that of the pretreated BR WAS.  The observed solubilization was 
consistent with prior research on HPTH WAS pretreatment. 
 
The soluble COD generated by pretreatment was characterized as Sbsc hence pretreatment increased 
the rate at which the BR WAS was aerobically degraded.  This conclusion was based on three results: 
 Pretreatment did not generate Sus because it was shown that the average ffCOD 
concentrations in the AD WAS in Phases 1 and 2 were statistically equivalent.  This finding 
was consistent with literature reports that have shown that refractory compounds, i.e. Sus, 
were only generated at pretreatment temperatures above 150
o
C. 
 The offline respirometric tests showed that the OUR curve for inoculated pretreated BR WAS 
peaked earlier and to a higher value than the OUR curve for the inoculated raw BR WAS.  
This response was characteristic of growth on Sbsc. 
 The offline respirometric tests showed that the OUR in the filtered BR WAS was negligible, 
indicating the absence of Sbsc.  By comparison, the area under the OUR curve for filtered 
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pretreated BR WAS contributed more than 60% of the area under the curve for whole 
pretreated BR WAS, demonstrating that pretreatment generated a substantial amount of Sbsc. 
 
Although pretreatment increased the rate at which the BR WAS was aerobically biodegraded, it did 
not increase the extent of biodegradation.  The non-biodegradable COD component of the BR WAS, 
i.e. Ze, was not converted to biodegradable COD under the pretreatment conditions employed in this 
study.  This conclusion was based on the results of three independent tests: 
 The online respirometric data showed that the average ΣOUs/TCOD ratios for raw and 
pretreated BR WAS were statistically equivalent, demonstrating that the extent to which the 
BR WAS was degraded over the AD reaction period was not increased by pretreating the BR 
WAS.   
 Using the TCOD measurements from the sample bottles of the offline respirometric tests, it 
was shown that the average (TCODi – TCODf)/TCODi ratio for BR WAS was statistically 
equivalent to that for pretreated BR WAS.  This indicated that pretreatment did not change 
the fraction of the BR WAS that could be aerobically degraded by acclimatized inoculum. 
 The average measured VSS concentration in the AD WAS was statistically equivalent in 
Phases 1 and 2.  Had pretreatment increased the aerobically biodegradable fraction of the BR 
WAS, it was expected that the VSS concentration in the AD would have decreased. 
 
A COD-based stoichiometric pretreatment model was developed for HPTH pretreatment at 150
o
C and 
3 bars for 30 minutes.  When this model was integrated into BioWin, it was able to accurately 
simulate both the steady state performance of the overall system employed in this study as well as 
dynamic respirometry results.  The experimental results showed that the TCOD of the BR WAS 
consisted of 51% Zbh, 12% Ze and 37% XSTO and the pretreated BR WAS consisted of 12% Ze and a 
negligible amount of Zbh.  The pretreatment model verified these fractions and predicted that the 
pretreated BR WAS also contained 54% Sbsc and 32% Xsp.  Two kinetic processes with effectively 
instantaneous rates were included in the pretreatment model: XSTO was fully converted to Sbsc; and 
36% of Zbh was converted Sbsc and the remaining Zbh was converted to Xsp.  The approach described 
in this study may be followed to determine the impacts of pretreatment on Zbh, Ze and XSTO when 







The experiments and modeling procedures carried out in this study were successfully used to 
characterize the impacts of HPTH pretreatment on WAS containing Zbh, Ze and XSTO.  Several 
recommendations are provided to improve the approach in future studies: 
 The rate of oxygen transfer in the AD should be increased such that the time to raise the DO 
concentration from the low to high set point is less than one minute, especially after the AD is 
fed.  This will allow the online respirometric test to capture rapid and high oxygen uptake.  
To achieve this, the current aerators should be replaced by aerators with much higher oxygen 
transfer efficiencies.  Alternatively, the OUR in the AD could be reduced by adding the BR 
WAS over one or two hours instead of all at once. 
 Phase 2 should only be commenced after at least two valid offline respirometric tests with 
reproducible results have been obtained for pretreated BR WAS with non-acclimatized 
inoculum.  This will allow the impacts of biomass adaptation on the aerobic biodegradability 
of WAS by HPTH pretreatment to be more reliably determined.   
 Phosphorous species should be measured in the various sludge streams during Phases 1 and 2 
to determine the associated impacts of HPTH pretreatment.  The COD: N: P ratio of the 
synthetic feed employed by the current study was 100: 4.4: 1.5 hence the concentration of 
monopotassium phosphate in the synthetic wastewater may have been excessively high.  
Using the measurements of the phosphorous species, a phosphorous balance could be used to 
determine whether the monopotassium phosphate concentration in the synthetic wastewater 
should be decreased.   
 Storage products in the BR WAS should be eliminated to simplify the COD fractionation of 
the sludge streams and the modeling of the overall system.  Without significant stored COD, 
it is believed that the system could be successfully simulated with the BioWin 3.1® 
Integrated Model.  It was hypothesized that the BR biomass stored COD such as glycogen or 
PHA due to the alternating anaerobic and aerobic conditions in the reactor.  Although the 
measured DO concentration was above 2 ppm for most of the reaction period, it was close to 
zero for up to two hours after feeding.  Thus the operation of the BR should be changed to 
eliminate any anaerobic conditions.  For example, the synthetic wastewater could be fed to 
the BR over an extended period of time.  If storage products are still detected after improving 
the BR operation, the cells could be microbiologically examined using a suitable staining 




The approach described in this project with the improvements recommended above should be applied 
to the following future studies: 
 Investigation of the impacts of HPTH pretreatment on Xi.  Instead of synthetic wastewater, 
the BR-AD system could be fed with screened raw municipal wastewater which would 
contain Xi.  Thus the non-biodegradable particulate COD in each sludge stream would be the 
sum of Xi and Ze.  Since the constituent concentrations in municipal wastewater vary with 
time, Phases 1 and 2 would each need to be operated long enough to accurately estimate the 
COD fractions.  Using the VSS measurements and analyses of the online and offline 
respirometric data, the impact of pretreatment on the extent of aerobic biodegradability of the 
BR WAS could be determined.  A significant increase would suggest that Xi was partially 
converted to bCOD by pretreatment since it was shown that Ze is not affected.   
 Investigation of the impacts of HPTH pretreatment at temperatures above and below 150oC 
and the development of corresponding pretreatment models.  Prior research suggests that the 
relative proportion of Sbsc to Xsp in the pretreated WAS may increase with pretreatment 
temperature however it has also been shown that refractory compounds, i.e. Sus, may be 
generated at temperatures above 150
o
C.  It should be determined whether other pretreatment 
temperatures can change the aerobically biodegradable fraction of the WAS. 
 Investigation of the impacts of other pretreatment techniques such as sonication and 
ozonation and the development of COD-based stoichiometric pretreatment models that 
accurately characterize each technique.   
 
The approach in the current project should be combined with investigations of the impacts of HPTH 
pretreatment on other biomass fractions besides Zbh so that appropriate processes may be added to the 
pretreatment model.  In WWTPs, heterotrophs that accumulate phosphorus and bacteria that oxidize 
ammonia and nitrite are present in significant quantities in the activated sludge and would likely be 
affected by HPTH pretreatment.  Frigon and Isazadeh (2010) showed that pretreatment with ozone 
did not reduce the level of each type of biomass to the same degree.  Further research is required to 
determine whether such a trend exists for HPTH pretreatment.   
 
It is recommended that the approach described in this project be paired with an analysis of the 
impacts of HPTH pretreatment on the rate and extent of anaerobic biodegradability.  This is an 




 are used 
in conjunction with anaerobic digestion.  Biochemical methane potential tests could be carried out on 
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Table A.1 Synthetic Wastewater 
Date 
Sampled 
COD (mg/L) SS (mg/L) 
pH 
TCOD SCOD PCOD ffCOD TSS VSS ISS 
13 2508 1082 1426 
     19 2018 
      
8.0 
19 2182 
      
8.0 
34 7557 
       36 7201 
   
1320 1320 0 6.0 
41 4664 
   
1250 930 320 
 43 5225 
       48 5761 
      
3.9 
69 7715 
       76 7806 
       83 7108 
       85 7432 
       117 
       
4.6 
119 7379 
      
6.2 
172 
       
4.5 
175 8754 6223 2531 5836 2210 1940 270 4.5 
181 4153 2918 1235 2718 1090 900 190 4.6 
193 3903 3080 823 2768 1020 860 160 4.6 
225 3654 2862 792 2619 810 750 60 4.5 
273 4103 2993 1110 
    
4.5 
273 4028 2980 1047 
 
920 880 40 4.5 
273 4190 3030 1160 
 
880 820 60 4.5 
278 4015 3018 998 2899 880 790 90 4.5 
*Mean 4006 2983 1023 2751 933 833 100 4.53 
*Std. dev. 183 73 166 117 103 57 61 0.05 
 




Table A.2 BR WAS 
Date 
Sampled 
COD (mg/L) SS (mg/L) pH N (mg/L) 
TCOD SCOD PCOD ffCOD TSS VSS ISS 
 
NO3 NH3 
11 3283 52 3230 
 
3780 3210 570 
   
21 4150 54 4096 
    
9.3 
  
27 4988 180 4808 
       
34 9326 245 9081 
 
8350 6900 1450 9.4 
  
36 8218 200 8018 
 
7950 6540 1410 7.0 
  
40 
       
9.2 0.5 
 
41 7328 176 7152 
 
7470 6050 1420 9.2 0.5 
 
48 7258 121 7137 




       
8.6 1.05 
 
69 8068 145 7923 267 
   
8.1 
  
70 8611 202 8409 
    
8.7 
  
76 10451 202 10249 160 




         
83 11871 140 11732 








       
8.6 0.45 
 
91 8554 142 8412 
    
8.6 
  
92 8953 151 8803 113 8180 7120 1060 8.3 
  
103 7519 928 6592 
 
11630 5330 6300 6.5 
  
105 7108 922 6186 
 
6200 5580 620 7.8 
  
105 6603 955 5648 




       
7.5 0.45 231 
113 4664 688 3975 708 
   
7.9 
  
116 8916 828 8088 
    
6.4 0.85 
 
118 9851 1465 8386 




       
8.6 1 160 
124 9178 1665 7513 1634 
   
7.7 
  
124 8863 1771 7092 1702 
   
7.7 
  
127 9053 1334 7719 
    
8.2 0.8 202 
132 
       
8.4 1.15 150 
133 
       
8.6 0.8 
 
134 9203 1646 7557 




       
8.2 0.7 
 
160 7806 1913 5893 
    
4.8 0.9 294 
162 6989 280 6709 
    
8.1 1.3 184 
163 8280 








       
7.9 0.6 
 
175 9502 1877 7625 1833 7520 6640 880 7.6 0.5 236 
179        8.3 0.4  





Table A.3 BR WAS 
Date Sampled 
COD (mg/L) SS (mg/L) TCOD/
VSS TCOD SCOD PCOD ffCOD TSS VSS ISS 
193 4489 165 4325 47 3990 3330 660 1.35 
196 5761 165 5597 81 6590 2765 3825 2.08 
203 4053 90 3963 85 3840 3260 580 1.24 
208 4651 54 4598 59 
    209 3878 
   
4150 3530 620 1.10 
215 3753 59 3695 46 3620 3140 480 1.20 
222 4078 35 4043 49 3820 3330 490 1.22 
223 4365 54 4311 
     228 4327 44 4283 44 3990 3430 560 1.26 
232 
        233 




    
4030 3530 500 0.00 
243 3953 46 3907 47 3600 3140 460 1.26 
250 4040 49 3992 50 3420 3180 240 1.27 
258 3878 46 3832 59 3560 3130 430 1.24 
264 4626 56 4570 59 3960 3460 500 1.34 
271 4502 56 4446 51 3820 3400 420 1.32 
278 4539 51 4488 45 4210 3570 640 1.27 
283 
        *Mean 4170 52 4127 53 3835 3342 489 1.23 
*Std. dev. 324 14 334 12 246 167 103 0.08 
 









N (mg/L) pON/ 
pCOD NO3 NH3 TKN sTKN 
193 8.3 1.40 74 
   196 8.4 1.00 86 
   203 8.1 0.10 85 
   208 8.5 0.10 74 
   209 8.5 
     215 8.2 0.10 69 
   222 8.5 0.10 54 
   223 8.5 
     228 8.5 0.10 48 
   232 8.6 
  
266 99 
 233 8.5 0.10 70 
   236 8.5 0.10 76 258 85 0.046 
237 8.3 
     243 8.0 0.10 78 277 79 0.051 
250 8.6 0.10 79 301 87 0.053 
258 8.4 0.20 74 285 81 0.053 
264 8.6 0.20 73 284 78 0.045 
271 8.4 0.10 84 348 90 0.058 
278 8.3 0.40 80 358 80 0.062 
283 8.5 
     *Mean 8.52 0.14 73 297 85 0.053 
*Std. dev. 0.12 0.09 11 36.9 7 0.006 
 




Table A.5 Pretreated BR WAS 
Date 
Sampled 
COD (mg/L) SS (mg/L) TCOD/
VSS TCOD SCOD PCOD ffCOD TSS VSS ISS 
193 4228 2470 1758 1853 2098 1657 441 2.55 
196 4305 2080 2225 1560 1917 1514 403 2.84 
197 4285 2005 2280 1504 2100 1659 441 2.58 
200 4105 2503 1602 1877 
    201 4366 2494 1872 1871 
    202 4315 2510 1805 1883 
    203 4100 2320 1780 1740 2320 1833 487 2.24 
209 4215 2606 1609 1846 2090 1590 500 2.65 
215 4165 2506 1659 1746 1970 1440 530 2.89 
222 4153 2669 1484 1802 1660 1270 390 3.27 
223 4290 2494 1796 
     228 4402 2694 1708 2001 1740 1240 500 3.55 
236 4090 2475 1615 1908 
    237 
    
1840 1440 400 
 243 3778 2213 1565 1715 1720 1280 440 2.95 
250 3965 2213 1752 1546 1830 1780 50 2.23 
254 
    
1610 1210 400 0.00 
258 3741 2176 1565 1727 2280 1730 550 2.16 
264 4227 2226 2001 1659 2200 1710 490 2.47 
271 4365 2076 2288 1652 2020 1710 310 2.55 
278 4315 2082 2232 1378 2270 1810 460 2.38 
283 
        *Mean 4142 2369 1773 1725 1936 1518 412 2.73 
*Std. dev. 215 228 264 171 237 230 131 0.79 
 








N (mg/L) pON/ 
pCOD NO3 NH3 TKN sTKN 
193 7.3 2.1 
    196 6.1 2.2 108 
   197 7.5 3.8 88 
   200 7.2 4.5 97 
   201 7.8 1.2 75 
   202 7.8 5 79 
   203 7.6 3.0 81 
   209 7.9 2.1 84 
   215 7.7 1.8 83 
   222 8.1 1.8 59 
   223 7.9 
     228 8.1 2.4 62 
   232 7.9 
  
309 231 
 233 7.8 2.1 81 
   236 7.6 2.5 95 281 198 0.051 
237 7.7 
     243 8.0 2.2 92 262 184 0.050 
250 7.9 3.1 92 276 200 0.043 
254 8.2 
     258 8.0 4.1 87 314 205 0.069 
264 8.0 3.9 96 286 193 0.047 
271 8.0 3.9 91 306 196 0.048 
278 7.7 3.9 92 317 210 0.048 
283 7.5 
     *Mean 7.8 2.9 84 294 202 0.052 
*Std. dev. 0.2 1.1 12 20 14 0.016 
 






Table A.7 AD WAS 
Date 
Sampled 
COD (mg/L) SS (mg/L) 
pH 
N (mg/L) 
TCOD SCOD PCOD ffCOD TSS VSS ISS NO3 NH3 
27 6709 185 6524 
       34 11809 429 11380 
 
11880 9140 2740 9.3 
  36 11491 370 11121 
 
12590 9540 3050 9.3 
  41 13037 379 12658 
 
15000 10950 4050 9.3 1.5 
 63 
       
8.4 3.9 
 69 16909 
      
8.1 
  70 16305 409 15896 
    
8.0 
  78 14590 625 
 
352 
    
415 
 83 10924 549 13965 





    
6.3 335 
 91 9527 481 
     
6.1 




    
7.9 198 
 103 6385 269 
  








105 5836 248 
  
5580 4530 1050 8.3 
  112 
  
5588 
    
8.3 12 213 
116 3965 251 
     
8.3 34 
 118 5237 364 3715 
    
8.0 
  120 
  
4873 
    
6.5 305 29 
124 6609 451 
 
408 
   
6.9 
  127 6011 414 6158 
    




    
8.4 160 0 
134 5138 448 





    
8.7 0.9 
 160 4053 434 
     




    
8.6 0.7 176 
163 3816 424 
     




    
8.5 0.8 
 174 
       
8.3 50 
 175 4788 426 
 




    
8.5 8.5 
 181 4639 416 
 
267 5120 3460 1660 8.3 3.4 
 186        8.4 2.2  





Table A.8 AD WAS Phase 1 
Date 
Sampled 




TCOD SCOD PCOD ffCOD TSS VSS ISS NO3 NH3 
197 2207 340 1.36 203 2510 1620 890 1.36 8.5 1.0 122 
201 2556 304 1.62 183 2570 1580 990 1.62 8.4 0.7 106 
203 2519 282 1.40 185 2860 1800 1060 1.40 8.3 0.6 107 
*Mean 2427 309 1.46 190 2647 1667 980 1.46 8.40 0.8 112 
*Std dev 192 30 0.14 11 187 117 85 0.14 0.10 0.2 9 
 
*Mean and standard deviation of data from day 197 to 203 when the AD was at steady-state during Phase 1 
 
Table A.9 AD WAS Phase 2 
Date 
Sampled 
COD (mg/L) SS (mg/L) TCOD
/VSS TCOD SCOD PCOD ffCOD TSS VSS ISS 
208 2234 269 1965 165 
    209 2120 258 1862 167 2190 1410 780 1.50 
215 2132 301 1832 190 2100 1390 710 1.53 
222 1833 337 1496 207 1700 1270 430 1.44 
228 2051 315 1736 213 1780 1250 530 1.64 




    
2070 1560 510 
 243 2114 271 1843 197 2010 1430 580 1.48 
250 2164 239 1924 188 2160 1640 520 1.32 
258 2114 241 1873 201 2120 1633 487 1.29 
264 2014 269 1745 200 1950 1480 470 1.36 
271 2058 205 1853 151 2070 1530 540 1.34 
278 2126 197 1929 126 2200 1630 570 1.30 
283 
        *Mean 2098 237 1861 177 2085 1557 528 1.39 
*Std. dev. 53 31 67 31 94 90 44 0.08 
 





Table A.10 AD WAS Phase 2 
Date 
Sampled pH 
N (mg/L) pON/ 
pCOD NO3 NH3 TKN sTKN 
208 8.4 0.6 103 
   209 8.3 0.6 104 
   214 8.4 1.5 
    215 8.2 1.6 99 
   222 8.5 1.1 87 
   228 8.4 1.2 62 
   232 8.1 
  
273 188 
 233 8.4 1.2 86 
   236 8.4 1.1 97 231 108 0.059 
237 8.3 
     243 8.1 0.9 90 222 97 0.068 
250 8.4 0.8 89 263 108 0.081 
258 8.2 0.9 90 253 104 0.079 
264 8.2 1.0 113 251 121 0.075 
271 8.2 0.7 103 297 119 0.096 
278 8.1 1.0 100 299 112 0.097 
283 8.0 
     *Mean 8.32 0.9 98 264 110 0.075 
*Std. dev. 0.16 0.1 10 29 9 0.012 
 











Figure B.1 Phase 2 Day 197 to 199 
 
Figure B.2 Phase 2 Day 206 to 208 
 





Figure B.4 Phase 2 Day 228 to 230 
 
Figure B.5 Phase 2 Day 234 to 236 
 





Figure B.7 Phase 2 Day 246 to 248 
 
Figure B.8 Phase 2 Day 252 to 254 
 





Figure B.10 Phase 2 Day 264 to 266 
 
Figure B.11 Phase 2 Day 270 to 272 
 






Figure B.13 Phase 2 Day 280 to 282 
 















Figure C.1 BR WAS and AD WAS - Test Started on Day 193 
 
 






Figure C.3 Pretreated BR WAS and Non-acclimatized AD WAS – Test Started on Day 197 
 
 






Figure C.5 Pretreated BR WAS and Acclimatized AD WAS – Test Started on Day 222 
 
 






Figure C.7 Pretreated BR WAS and Acclimatized AD WAS – Test Started on Day 236 
 
 






Figure C.9 Pretreated BR WAS and Acclimatized AD WAS – Test Started on Day 250 
 
 
Figure C.10 Pretreated BR WAS and Acclimatized AD WAS – Test Started on Day 271 
 
 
 
